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ABSTRACT 
GLYCINE RECEPTOR EXPRESSION ACROSS IDENTIFIED  
RETINAL GANGLION CELL TYPES 
 
Ian Scot Pyle 
April 9, 2019 
 
Retinal ganglion cells (RGCs) represent the culmination of all retinal 
signaling and their output forms the substrate for vision throughout the rest of the 
brain. About 40 different RGC types have been defined by differences in their 
visually evoked responses, morphology, and genetic makeup. These responses 
arise from interactions between inhibition and excitation throughout the retinal 
circuit (Franke et al., 2017; Masland, 2012; Sanes & Masland, 2015; Werblin, 
2011). Unlike most other areas of the central nervous system (CNS), the retina 
utilizes both GABA and glycine inhibitory neurotransmitters to refine glutamatergic 
excitatory signals (Franke & Baden, 2017; Werblin, 2011; C. Zhang, Nobles, & 
McCall, 2015). Glycine receptors (GlyRs) are heteromers composed of a single β 
subunit and one of four α subunits, with a stoichiometry of 3β:2α (Grudzinska et 
al., 2005; Heinze, Harvey, Haverkamp, & Wassle, 2007; Lynch, 2004). All four 
GlyRα subunits (α1, α2, α3, or α4) are differentially expressed in the retina and 
subunit specific expression has been defined for bipolar, some amacrine cells and 
 
 
vi 
 
RGCs (Haverkamp, Muller, Zeilhofer, Harvey, & Wassle, 2004; Heinze et al., 
2007). The roles for GlyRα subunit specific inhibition are unknown, although 
glycinergic input is generally linked to temporal response tuning (Murphy & Rieke, 
2006; Nobles, Zhang, Muller, Betz, & McCall, 2012; van Wyk, Wassle, & Taylor, 
2009; Wassle et al., 2009; Werblin, 2010). We have surveyed GlyRα subunit 
expression in a variety of identified RGC types, using GlyRα knockout mice and 
an rAAV-mediated RNAi to knockdown GlyRα subunit specific expression. We find 
that the four α RGCs only express GlyRα1. All of the other RGCs we studied 
express at least two GlyRα subunits. In some RGCs, the GlyR kinetics are similar, 
whereas in others the kinetics differs. We propose that this diversity will contribute 
to the richness of retinal inhibitory processing. 
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CHAPTER I 
INTRODUCTION 
1.1 The Visual system 
 
Critical to an organism’s proliferation and survival is its ability to interact with 
its environment. More than 500 million years ago, organisms developed 
rudimentary photoreceptors to convert energy (light) into information to understand 
their surroundings and improve survival outcome. Throughout evolution, the 
mammalian visual system became a complex arrangement of neurons and 
developed the ability to filter and interpret an ever-changing visual scene. This 
process of filtering and interpreting occurs in neural tissue in the eye, called the 
retina, and happens rapidly, on the order of tens of milliseconds. In the initial stages 
of processing, a diverse array of circuits segregate information into distinct 
channels even before transmission to the brain. The parsing of information makes 
the visual system more efficient at transmitting signals and interpreting the visual 
scene. The retina utilizes complex interactions between inhibitory and excitatory 
neurons that are specialized within their particular circuit to create these channels. 
Excitatory neurons typically release neurotransmitter onto post-synaptic cells 
which bind to excitatory receptors allowing an influx of sodium or potassium ions 
to depolarize the post-synaptic cell membrane
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 Conversely, inhibitory neurons typically release neurotransmitters, which 
bind to inhibitory receptors on post-synaptic cells allowing an influx of chloride ions 
into the cell. These ions hyperpolarize the membrane and reduce the probability 
of an action potential or help modulate excitatory output. Our understanding of the 
interplay of the visual excitatory and inhibitory circuits requires systematic study of 
the receptors and their ligands that shape neuronal responses within the retina. 
My dissertation will focus on one class of inhibitory receptors that are sensitive to 
the neurotransmitter glycine. 
1.2 The Retina 
 
The retina is a thin piece of neural tissue (approximately 150 to 400 μm thick 
depending on species and the position of the retina measured), located at the back 
of the eye, where phototransduction first occurs (Ferguson, Dominguez, Balaiya, 
Grover, & Chalam, 2013; Yamada, 1969). The retina is a laminar structure 
consisting of five different classes of neurons and two synaptic layers. These cells 
classes include the photoreceptors, horizontal cells, bipolar cells, amacrine cells, 
and ganglion cells (Figure 1.1). Retinal neuron somas reside in three nuclear 
layers: the outer nuclear layer (ONL) contains photoreceptors; the inner nuclear 
layer (INL) contains bipolar cells, horizontal cells, and amacrine cells; the ganglion 
cell layer (GCL) contains ganglion cells and displaced amacrine cells (Figure1.1). 
In between the cellular layers are two synaptic layers called plexiform layers. The 
photoreceptors, horizontal cells, and bipolar cells synapse in the outer plexiform 
layer (OPL) while the bipolar cells, amacrine cells, and ganglion cells synapse in 
the inner plexiform layer (IPL, Figure1.1). These retinal cells synapse together and 
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form the parallel circuits, which parse, filter, and process visual input and transmit 
interpretable visual signals to the brain such as the ONset and OFFset of light, 
direction selectivity, and edge detection. 
 
Figure 1.1 Schematic of the retina. Source: modified figure from (C. Zhang, 
2015). The retina contains five unique classes of cells: photoreceptors (PR), 
horizontal cells (HC) bipolar cells (BC), amacrine cells (AC) and ganglion cells 
(GC). The cell somas are found in the nuclear layers: the outer nuclear layer 
(ONL), the inner nuclear layer (INL), and the ganglion cell layer (GCL). Retinal 
cell dendrites connect via synapses in the plexiform layers: the outer plexiform 
layer (OPL) and the inner plexiform layer (INL). Light passes through the retina 
before falling upon the photoreceptor outer segments. Some amacrine cell 
somas are found in the GCL and are called displaced amacrine cells (DAC). 
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1.3 Photoreceptors 
The photoreceptors are comprised of two major classes: rods and cones. 
Rods are more sensitive to light at the cost of visual acuity. One rod cell can detect 
a single photon, which allows them to function in scotopic, or dim light, conditions 
(a luminance of 10−6 to 10−2 cd/m²) (Hecht, Shlaer, & Pirenne, 1941; Tinsley et al., 
2016). Rods transmit lower visual acuity because of the signal convergence of 
multiple rods to single bipolar cell targets. Conversely, cone cells are less sensitive 
to light, but have greater visual acuity. This increased visual acuity is due to less 
signal convergence of cones to their bipolar cell targets; in some cases, only one 
cone makes synapses with one bipolar cell target. They primarily function in 
photopic or sunlit conditions (a luminance of 1 to 106 cd/m²). With two different 
classes of photoreceptors, a mammal, for instance, can interact in an environment 
consisting of wider ranges of light diversity. Similarly, most human retinas have 
three different types of cone photoreceptors, each being stimulated by a specific 
wavelength of light within the visible spectrum. These three cone types allow the 
brain to perceive color, again widening the range of environmental interpretation. 
Light in the 400-500nm wavelength range is on the lower end of the detectable 
range and is coded by cones called short wavelength (S) cones. Medium 
wavelength (M) cones detect light in the 500-600nm range, and long (L) cones 
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detect light in the 550-650nm wavelength range (Figure 1.2) (Bowmaker & 
Dartnall, 1980).  
Figure 1.2 Absorbance Spectrum of trivariant color vision from three different 
cones. A short (S) cone has an absorbance around 400-450nm wavelength 
(blue). A medium (M) cone has an absorbance around 500-575nm wavelength 
(green). A long (L) cone has an absorbance around 550-650nm wavelength 
(red). 
1.4 Photoisomerization  
 
Photopigments called opsins are light-sensitive proteins that reside in the 
outer segment discs of photoreceptors and begin the conversion of light energy 
into neural information. There are two types of opsins, one for rods called 
rhodopsin, and one for cones called cone opsin (Lamb, 2013). While a 
photoreceptor is in the dark, (or photons have not activated an opsin), 
photoreceptor membrane-bound cGMP-gated cation channels are open, Na2+ and 
Ca2+ enter the cell, which causes the photoreceptor cell to depolarize and release 
glutamate (Dowling & Ripps, 1973; Suryanarayanan & Slaughter, 2006; Trifonov, 
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1968). This results in a constant depolarizing current in the dark (called the dark 
current), and it leads to sustained glutamate release in the absence of photon 
activation. However, once an opsin absorbs a photon, which causes 
photoisomerization, the membrane-bound cGMP-gated cation channels close, 
causing the photoreceptor cell membrane to hyperpolarize (Morgans, 2000). This 
reduces glutamate release from the photoreceptor proportionally to the intensity of 
light (i.e., the number of photons absorbed in the photoreceptor). The light-evoked 
signal is then transmitted through parallel circuits formed by the bipolar cells, 
amacrine cells, and ganglion cells and sent to the brain.  
1.5 Bipolar Cells 
 
Bipolar cells are the major excitatory interneurons in the retina. The bipolar 
cells form synaptic connections with the photoreceptors in the OPL and with the 
amacrine cells and ganglion cells in the IPL (Figure 1.1). At least fourteen different 
types of bipolar cells are found in the mammalian retina (Euler, Haverkamp, 
Schubert, & Baden, 2014; Greene, Kim, Seung, & EyeWirers, 2016). Bipolar cells 
fit into two major classes based on their presynaptic photoreceptor partner. Rod 
bipolar cells are postsynaptic to rods and cone bipolar cells are postsynaptic to 
cones. However, there are instances where cones make synapses on rod bipolar 
cells, so a general characterization is not entirely accurate (Pang, Yang, Jacoby, 
& Wu, 2018). 
Cone bipolar cells can be further divided into two major varieties, OFF and 
ON. These two major varieties are the bases for the OFF and ON pathways within 
the retina (Ghosh, Bujan, Haverkamp, Feigenspan, & Wassle, 2004). While in the 
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dark, both OFF and ON cone bipolar cells continually receive tonic glutamate from 
cone photoreceptors. However, in the dark, the OFF cone bipolar cells are 
depolarized and release glutamate in the IPL whereas the ON cone bipolar cells 
are hyperpolarized and do not release glutamate. Hence, at the bipolar cell level, 
the OFF pathway is more excited in the dark with little inhibition, and the ON 
pathway is tonically inhibited. Conversely, when photons activate photoreceptors, 
glutamate release is interrupted, so both OFF and ON cone bipolar cells receive 
less glutamate. In the light, OFF cone bipolar cells hyperpolarize and stop 
releasing glutamate into the IPL, while ON cone bipolar cells depolarize and 
release glutamate into the IPL. Therefore, the ON pathway is excited in the 
presence of light, while the OFF pathway receives more inhibition. 
To maintain the division between the OFF and ON pathways, OFF cone 
bipolar cells form synaptic connections with OFF ganglion cells in the upper region 
of the IPL (Figure 1.1). This region is called the OFF sublamina of the IPL. 
Similarly, the ON cone bipolar cells form synaptic connections with ON ganglion 
cells in the lower region of the IPL called the ON sublamina (Figure 1.1). Though 
the cone bipolar cells help define these pathways, the rod bipolar cells indirectly 
connect to both of these major parallel pathways. In contrast to the cone bipolar 
cells, the rod bipolar cells form synaptic connections with bistratified AII amacrine 
cells but not retinal ganglion cells (RGCs) (Bloomfield & Dacheux, 2001; Demb & 
Singer, 2012) (Figure 1.1). In turn, the AII amacrine cell forms gap junctions with 
the ON cone bipolar cells where an excitatory signal can transmit onto the ON 
ganglion cells (Demb & Singer, 2012). Additionally, the AII amacrine cell is 
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bistratified and also forms inhibitory synaptic connections with the OFF cone 
bipolar cells, which in turn are synaptically coupled to OFF ganglion cells (Demb 
& Singer, 2012). These three different functional types of bipolar cells are the 
foundation for the major parallel pathways in the retina: the ON pathway, the OFF 
pathway, and the rod bipolar cell pathway. 
1.6 Horizontal Cells 
 
 Horizontal cells are one of the major inhibitory neurons in the retina. Located 
in the INL, their dendrites innervate the OPL where they form synapses with 
photoreceptors. The primary role of horizontal cells is they form a negative 
feedback loop to the photoreceptors, utilizing either with a hemichannel-mediated 
ephaptic mechanism, and/or Na/HCO3 transporters modulating the local pH of 
photoreceptor cell and bipolar cell synapses (Byzov & Shura-Bura, 1986; 
Fahrenfort et al., 2009; Kamermans et al., 2001). These cells also release γ-
Aminobutyric acid (GABA), but the role of this neurotransmitter is unclear 
(Fahrenfort et al., 2009; Kamermans & Werblin, 1992). This feedback loop has 
been shown to have an essential role in color constancy and opponency, contrast 
enhancement, and forming center-surround receptive fields of cones (Chapot, 
Euler, & Schubert, 2017; Kamermans & Werblin, 1992). Horizontal cells are 
connected to each other via gap junctions to form an interconnected network 
(Kamermans & Werblin, 1992).  
1.7 Amacrine Cells 
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To date, there are approximately forty known types of amacrine cells 
(Akrouh & Kerschensteiner, 2015; Helmstaedter et al., 2013; Masland, 2012). The 
primary function of amacrine cells is to release neurotransmitter (GABA or glycine) 
into the inhibitory synapses of ganglion cells or bipolar cells or both to integrate 
and modulate these cells excitatory output (Park et al., 2018; C. Zhang & McCall, 
2012). Some amacrine cells also release less conventional neurotransmitters, 
including acetylcholine (S. Lee et al., 2014; Park et al., 2018). The somas of 
amacrine cells can occupy either the INL where the bipolar cell somas reside or 
the ganglion cell layer where amacrine cells are called displaced amacrine cells 
(Figure 1.1). The location of the IPL where amacrine cell dendrites ramify and 
whether these dendrites are monostratified, bistratified, or diffuse are the two major 
factors that determine the type of circuit with which the amacrine cell is involved. 
To date, only narrow-field amacrine cells release glycine and wide-field amacrine 
cells release GABA. Co-release of GABA and glycine in a synapse is observed in 
regions such as the lateral superior olive, the medial nucleus of the trapezoid body, 
and a variety of locations in the spinal cord (Gamlin, Yu, Wong, & Hoon, 2018; 
Moore & Trussell, 2017). However, co-release of GABA and glycine has yet to be 
observed in the retina. By releasing neurotransmitter into inhibitory synapses of 
bipolar cells or RGCs, amacrine cells facilitate the function of four major types of 
inhibitory circuits. 
1.8 Inhibitory Circuits 
 
The four important inhibitory circuits involving amacrine cells are: 
feedforward and feedback, which provide direct inhibition onto their postsynaptic 
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targets and crossover and serial circuits, which provide disinhibition onto their 
postsynaptic targets.  
An inhibitory feedforward circuit consists of a neuron, which depolarizes and 
excites an inhibitory neuron to release neurotransmitter onto the inhibitory 
receptors of a third neuron (Figure 1.3A). Succinctly, the excitatory output of the 
first neuron causes the second neuron to inhibit the third neuron (Figure 1.3A). An 
example of a feedforward circuit is that of a bipolar cell, which excites an amacrine 
cell to release inhibitory neurotransmitter onto a ganglion cell (Chen, Hsueh, 
Greenberg, & Werblin, 2010). 
 An inhibitory feedback circuit consists of a neuron, which depolarizes and 
excites an inhibitory neuron to release neurotransmitters onto the inhibitory 
receptors of the first neuron, thus inhibiting first cell (Figure 1.3B). An example of 
a feedback circuit is that of a rod bipolar cell, which releases glutamate (an 
excitatory neurotransmitter) onto A17 amacrine cells, which in turn release 
inhibitory neurotransmitter (GABA) back onto the rod bipolar cell (Hartveit, 1999). 
In addition, a feedback inhibitory circuit can be half of a reciprocal circuit where the 
inhibitory component helps enhance the excitatory component of the antagonist 
(in relevance to the inhibitory) target (Grimes, Zhang, Graydon, Kachar, & 
Diamond, 2010; Nobles et al., 2012). 
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Figure 1.3 Schematic Representations of Different Forms of Inhibition. Source: 
modified from (C. Zhang, 2015). A) Feedforward inhibition - excitation of an 
amacrine cell initiates inhibition of a bipolar cell or retinal ganglion cell B) 
Feedback inhibition - excitation of an amacrine cell starts feedback into the initial 
excitatory cell reducing further excitation. C) Crossover inhibition – excitation 
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from one pathway of a bistratified amacrine cell initiates inhibition of a bipolar cell 
or retinal ganglion cell of a different pathway D) Serial inhibition – excitation of an 
amacrine cell leads to the inhibition of another amacrine cell, which reduces its 
inhibitory output resulting in enhanced excitation of the final retinal ganglion cell 
target. This type of inhibition is disinhibition. 
 
An inhibitory crossover circuit consists of a neuron, which depolarizes and 
excites a bistratified inhibitory neuron to release neurotransmitter onto the 
inhibitory receptors of a third neuron, which receives excitatory input from a 
different pathway (Figure 1.3C). The bistratified neuron is a crucial component of 
crossover inhibition as it facilitates the signal transfer from one major pathway to 
another based on dendritic morphology. An example of this circuit is an ON cone 
bipolar cell excites an AII amacrine cell, which then inhibits an OFF ganglion cell 
(Demb & Singer, 2012). 
A serial inhibitory circuit consists of a neuron, which depolarizes and excites 
an inhibitory neuron, which releases neurotransmitter onto the inhibitory receptors 
of a second inhibitory neuron, which in turn stops releasing neurotransmitter onto 
the inhibitory receptors of a fourth cell (Figure 1.3D). The result in an enhancement 
of excitatory release to the fourth cell, otherwise known as disinhibition. An 
example of a serial inhibitory circuit is a rod bipolar cell stimulates a GABAergic 
amacrine cell, which then inhibits a second GABAergic amacrine cell. The second 
GABAergic amacrine cell then reduces the inhibition onto a second bipolar cell 
(Eggers et al. 2010). 
1.9 Retinal Ganglion Cells 
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Retinal ganglion cells, the feature detectors of the visual scene, transmit 
information about our rich and complex visual environment using spiking signals 
to the rest of the brain. The retinal ganglion cell somas reside in the retinal ganglion 
cell layer, and their dendrites stratify in the IPL and make synaptic connections 
with both bipolar cells and amacrine cells. The forty retinal ganglion cell types 
found in the mouse retina are defined by their: morphology, visual response 
properties, and genetic profiles (Baden et al., 2016; Bae et al., 2018; Rockhill, Daly, 
MacNeil, Brown, & Masland, 2002; Sanes & Masland, 2015). The circuits formed 
in the IPL between the excitatory output of the bipolar cells and inhibitory input of 
the amacrine cells onto the ganglion cells help complete the retina's interpretation, 
filtration, and feature detection of the signal of the visual scene. The axons of the 
retinal ganglion cells form the optic nerve and these axons innervate roughly 
twenty different areas in the brain; largely the superior colliculus, the lateral 
geniculate nucleus, and the suprachiasmatic nucleus of the hypothalamus 
(Canteras, Ribeiro-Barbosa, Goto, Cipolla-Neto, & Swanson, 2011; Ellis, Gauvain, 
Sivyer, & Murphy, 2016). 
1.10 Neurotransmission 
 
 Neurons form synapses with each other to orchestrate the transmission of 
these different modes of communication. Individual neurons can have as many as 
10,000 synaptic connections (Kandel, Schwartz, & Jessell, 2000). Both chemical 
and electrical synapses are found in the retina (Kuo, Schwartz, & Rieke, 2016). 
Electrical synapses, known as gap junctions are formed by twelve connexins that 
bridge between two cells and serve as a low resistance channel, which allows ions 
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to pass between them, effectively transferring charges between cells (Brink, 
Cronin, & Ramanan, 1996). 
Similarly, chemical synapses form between two cells (a pre-synaptic cell 
and a post-synaptic cell). However, chemical synapses form between a 
presynaptic bouton and either a small region of a dendrite or the soma of the post-
synaptic cell (Figure 1.4). In a chemical synapse, the presynaptic cell releases 
neurotransmitters, which are small peptides that act as ligands on the post-
synaptic cell receptors. Once a ligand binds to the post-synaptic cell receptor, the 
receptor responds by either opening an ionic channel to allow ions to flow across 
the membrane (ionotropic) or initiating a signal transduction cascade 
(metabotropic). The diversity of transferring information via a chemical synapse is 
staggering because of all of the different components at play. A number of different 
neurotransmitters have been identified in the retina. They include: glutamate, 
acetylcholine, GABA, glycine, and dopamine. Each appears to be stored in 
synaptic vesicles, when released bind to their respective excitatory or inhibitory 
postsynaptic receptors. The neurotransmitter release properties and the receptor 
kinetics differ and can have a major impact on the volume or quanta of 
neurotransmitter release and its uptake. Understanding these factors is critical to 
our interpretation of how circuits in the retina function and unveiling their roles in 
vision. 
1.11 Synaptic Release 
 
In preparation for release, neurotransmitters are packaged in synaptic 
vesicles in the presynaptic bouton and reside in one of three groups: the readily 
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releasable pool (there might be two of these, one for driven release, and one for 
spontaneous release), the reserve, or in the vesicle recycling pathway (Smith et 
al., 2012). Vesicle release can be either spontaneous or elicited by an action 
potential or graded electrical potential. Synaptic vesicles release their contents into 
the synaptic cleft via different mechanisms. A vesicle can fuse with the cell 
membrane and release all of its content via exocytosis; a method called full 
collapse. Or, vesicles can fuse with the cell membrane and release a portion of 
their contents, called partial collapse or fuse-pinch-linger. In a third mechanism, 
called kiss-and-run, a vesicle docks with a membrane pore, release a fraction of 
its contents, and then undocks from the pore. After a neurotransmitter enters the 
synapse, it can bind to a receptor, it can be taken up by a transporter, or if the 
concentration is high enough, it can diffuse out of the synapse.  
The release of vesicles can be spontaneous, or driven by input to the cell. 
Driven release is caused by excitation of the pre-synaptic cell and most or all 
vesicles from the readily releasable pool empty their contents into the synapse. 
Driven release can occur either synchronously, or asynchronously. Synchronous 
release is fast and clearance of the synapses happens rapidly (Eggers & 
Lukasiewicz, 2006b). Contrarily, Asynchronous release is slow, and 
neurotransmitter concentration remains high in the synapse, long enough to 
“spillover” and out of the synapse (Eggers & Lukasiewicz, 2006b; Keros & Hablitz, 
2005; Smith et al., 2012). Spillover often results in neurotransmitter binding to 
extrasynaptic receptors or receptors in a different synapse. (Eggers & Lukasiewicz, 
2006b; Keros & Hablitz, 2005).  
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The spontaneous release of the vesicles is stochastic, likely dependent on 
the extracellular calcium concentration of the presynaptic cell, and the 
spontaneously released vesicles come from a vesicle pool other than the readily 
releasable pool (Smith et al., 2012). Moreover, spontaneous release can involve a 
single vesicle release (univesicular) or multivesicular release. Univesicular release 
involves only one vesicle releasing its contents at a time; the spontaneous post-
synaptic currents that result from univesicular release are called “minis.” Mini’s also 
demonstrate the release of a single quantum of vesicle contents (Eggers & 
Lukasiewicz, 2006b; Moore-Dotson, Klein, Mazade, & Eggers, 2015). Multi-
vesicular release comprises of multiple vesicles releasing their contents into the 
synapse simultaneously. The simultaneous release of multiple vesicle contents 
results in larger post-synaptic current amplitude. Spontaneous release can be 
measured by recording the change in postsynaptic current via whole cell patch 
clamping. To isolate inhibitory inputs, the cell’s membrane potential is held at the 
reversal potential for cations (C. Zhang, Rompani, Roska, & McCall, 2014). These 
currents are then analyzed to answer questions related to spontaneous release. 
1.12 Inhibitory Receptors in the Retina 
 
In the central nervous system, inhibition shapes excitatory 
neurotransmission (Eggers, McCall, & Lukasiewicz, 2007). GABA receptors 
predominately mediate inhibition in the brain, whereas; glycine receptors 
predominately mediate inhibition in the spinal cord (Haverkamp, 1995; Haverkamp 
et al., 2004; Legendre, 2001). In addition to the spinal cord, glycine receptors are 
found in the brain stem, cerebellum, hippocampus, calyx of Held, and in the retina 
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(Hruskova et al., 2012; Manzke et al., 2010). Interestingly, both GABA and glycine 
receptors are expressed throughout the retina (Haverkamp et al., 2004; Nobles et 
al., 2012). 
In the retina, GABAARs expressed on retinal ganglion cells detect GABA 
release from wide field ACs, which mediate spatial properties of center and 
receptive field surround (Manookin, Beaudoin, Ernst, Flagel, & Demb, 2008; 
O'Brien, Richardson, & Berson, 2003). The GABAergic amacrine cells innervate 
either the ON or the OFF sublamina of the IPL to form serial inhibitory circuits or 
reciprocal inhibitory circuits (Veruki, Gill, & Hartveit, 2007). Small dendritic field 
bistratified or diffuse amacrine cells release glycine at their synapses with bipolar 
cells or RGCs within the IPL (Haverkamp, 1995; Haverkamp et al., 2004; Veruki et 
al., 2007; Weiss et al., 2008). Frequently, these amacrine cells cross over the ON 
and OFF sublamina of the IPL to facilitate crossover inhibition (MacNeil & Masland, 
1998; Nobles et al., 2012). My dissertation focuses on the expression of glycine 
receptors in the retinal ganglion cells. 
1.13 Glycine Receptors 
 
Glycine receptors are heteropentameric ligand-gated chloride ion channels. 
Figure 1.4A illustrates a typical glycine receptor containing one type of GlyRβ 
subunit and one of four different types of GlyRα-subunits (Fig1.5B) (GlyRα1, 
GlyRα2, GlyRα3, and GlyRα4; (Cascio, 2006; Dutertre, Drwal, Laube, & Betz, 
2012; Lynch, 2004, 2009; Wassle et al., 2009). The most predominant glycine 
receptors are heteromeric and are composed of three GlyRβ subunits and two 
GlyRα subunits (Figure 1.4C). Heteromeric expression of two different GlyRα 
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subunits within one GlyR has only been observed only in heterologous systems 
(e.g., Xenopus oocytes) (Figure 1.4C); (Kuhse, Laube, Magalei, & Betz, 1993). 
Homomeric GlyRs, made of five of the same GlyRα subunits, are rare but have 
been found in situ, for instance at the calyx of held (Figure 1.4C) (Hruskova et al., 
2012). To date, all four heteromeric GlyRs (GlyRα1, GlyRα2, GlyRα3, and GlyRα4) 
have been found in the mouse retina (Heinze et al., 2007; Veruki et al., 2007; 
Wassle et al., 2009; Y. Zhang, Dixon, Keramidas, & Lynch, 2015). 
 
Figure 1.4 Schematics of glycine receptors. Illustration sourced from the 
Australian Society for Biophysics. A) Illustration of the transmembrane 
heteropentameric chloride ion channel glycine made of three β subunits and two 
of the same α subunits. B) Illustration of a single α subunit of a glycine receptor. 
Each α subunit is made from four major transmembrane domains and both the N 
and C terminuses are on the extracellular portion of the subunit. The M2 domain 
of the α and β subunits face the interior of the channel pore. C) Illustration of a 
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heteromeric GlyRα1, heteromeric GlyRα3, and homomeric GlyRα2 glycine 
receptors. Notice the lack of β subunit in the homomeric GlyRα2 glycine receptor. 
  
1.14 Glycine Receptor Kinetics 
Receptor channel current kinetics are either derived from the subunit 
structure of the receptor, which can be influenced by auxiliary protein modulation 
such as phosphorylation. The receptor kinetics are measurable based on the 
current fluctuations they produce when opening and closing. These fluctuations 
are called postsynaptic currents. A current is evoked when a ligand binds to the 
postsynaptic receptor and opens the channel. In the case of glycine receptor 
channels, chloride ions flow into the cell until: a) the ligand dissociates from the 
receptor, which closes the channel or b) the channel desensitizes and closes after 
a certain timecourse. Current research suggests glycine receptors do not 
desensitize (Singer & Berger, 1999). While the glycine receptor channel is open, 
the inward flow of chloride ions hyperpolarizes the postsynaptic cell, which leads 
to inhibition. The timing of these glycinergic currents appears to depend primarily 
on the receptor alpha subunit, as the binding characteristics are similar for each 
subunit specific alpha receptor class. In addition, ligand concentration at the 
receptor, temperature, receptor expression density at the synapse, and 
phosphorylation of the glycine receptors also can modify the basic alpha receptor 
based current kinetics (Beato, 2008; Lynch, 2004; Maksay, 1996). Typical glycine 
concentration in the synaptic cleft is ~3mM and glycine is cleared by glycine 
transporters (GlyTs) in ~0.7 ms (Beato, 2008). Furthermore, glycine receptors are 
insensitive to rapid desensitization, which may help contribute to their ability to 
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match high frequency of excitatory inputs (Awatramani, Turecek, & Trussell, 2004; 
Singer & Berger, 1999).  
The different GlyRs are distinguishable from their spontaneous inhibitory 
post-synaptic currents (sIPSCs) (Figure 1.5). The sIPSCs that result from different 
GlyRα subunits have different kinetics, which include their rise time and decay time 
(τdecay). Rise time is defined as the time it takes for the amplitude of the sIPSC to 
rise from 10% to 90% of its peak (Figure 1.5A). The τdecay is defined as the time it 
takes for the current to fall from peak to 37% (D37) of the peak (Figure 1.5B). A 
shared characteristic across the four heteromeric glycine alpha receptors is a rapid 
rise time between approximately 2 and 7 ms (Gill, Veruki, & Hartveit, 2006; Russell 
& Werblin, 2010). Similarly, the four heteromeric glycine alpha receptors exhibit 
similar binding affinities, although these estimates vary across systems (Lynch, 
2004). The four heteromeric GlyR alpha subunit mediated sIPSCs have distinct 
τdecay times. (Table 1.1) (Majumdar, Heinze, Haverkamp, Ivanova, & Wassle, 2007; 
Majumdar, Weiss, & Wassle, 2009). Although estimates of the decays of the 
various alpha subunits have been published, the currents were recorded at room 
temperature, which is known to slow down current kinetics (Majumdar, Heinze, 
Haverkamp, Ivanova, & Wassle, 2007; Majumdar, Weiss, & Wassle, 2009). My 
experiments were conducted at 36° C and I found the τdecay is faster for each 
subunit compared to the previously published data (Table 1.1). Under these 
conditions, GlyRα1 has the fastest τdecay with an average of ~3ms; GlyRα3 has a 
slightly slower τdecay with an average of ~7ms, and GlyRα2 and GlyRα4 both have 
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much slower τdecay each with an average of ~20ms. These different decay kinetics 
suggest that the different types of GlyRs have specific independent functions as 
inhibitory receptors.  
Throughout the CNS, glycine receptors are associated with mechanisms 
that shaping temporal excitatory responses. They tune rhythmic motor output in 
the spinal cord, sustained and transient OFF responses in RGCs, and they match 
temporal suppression of high frequency excitatory responses in the mammalian 
calyx of Held (Awatramani et al., 2004; Bracci, Ballerini, & Nistri, 1996; Caldwell, 
Daw, & Wyatt, 1978; Nobles et al., 2012). The need for a variety of glycine receptor 
alpha subunit specific kinetics is demonstrated in inhibitory circuits found in both 
bushy and T stellate cells of the ventral cochlear nucleus (VCN). In the bushy cells 
of the VCN, kinetically slow GlyRs tonically adjust voltage-gated ion channels to 
modulate EPSC driven spike timing that ultimately increases the spike threshold 
and improves spike precision (Xie & Manis, 2013). Conversely, kinetically fast 
GlyRs expressed on the T stellate cells of the VCN mediate inhibition that 
coincides with fast EPSC input that does not interfere with spike threshold but 
inhibits slow NMDA currents (Xie & Manis, 2013). These two examples illustrate 
the need for precise temporal inhibition of varying kinetics, which can modulate 
specific excitatory signal in consonance or in interpolation.  
Table 1.1 (τdecay of GlyRα subtypes) 
GlyRα Subunit τdecay (ms) at 36°C 
α1 2.96±0.3 ms 
α2 26.59±0.5 ms 
α3 9.23±0.2 ms 
α4 21.85±0.4 ms 
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Figure 1.5 Representative examples of an IPSC waveform demonstrating both 
rise time and τdecay. The example of an IPSC rise time measurement is the time it 
takes for the amplitude to rise from 10% to 90% of the peak (in green). An 
example of an IPSC τdecay time measurement is the time it takes for amplitude to 
descend from the peak to 37% of the peak (in red). 
 
1.15 Differential Expression of GlyRα Subunits in the IPL of the retina 
 
In the retina, the GlyRβ subunit is expressed ubiquitously, whereas each of 
the GlyRα subunits is expressed differentially across the IPL (Figure 1.6). GlyRα1 
expression is found in both the OFF and ON sublamina of the IPL, with higher 
expression in the OFF sublamina of the IPL (Figure 1.6A). The expression is likely 
higher in the OFF sublamina because the AII amacrine cell (the most abundantly 
expressed amacrine cell) makes inhibitory synapses with OFF cone bipolar cells 
and OFF ganglion cells, while it makes gap junctions with ON ganglion cells (Demb 
& Singer, 2012). The GlyRα2 expression density throughout the IPL is the most 
 
 
23 
 
abundant of the GlyRs. (Figure 1.6B). The GlyRα3 expression is in four distinct 
bands across the IPL, which appear to be separated by the three calbindin bands 
(Figure 1.6C). Finally, GlyRα4 expression is concentrated in a distinct band in the 
upper ON sublamina and, with sparse expression throughout the rest of the IPL 
(Figure 1.6D). The combination of different decay kinetics and differential 
expression further implies functional differences among the four GlyR isoforms 
(Wassle et al., 2009).  
 
Figure 1.6 Representative confocal images of transverse wild type sections 
stained for glycine receptor subunit expression (green) across the IPL. A) GlyRα1 
puncta expression is distributed throughout the IPL, but more abundant in the 
OFF sublamina. B) GlyRα2 puncta expression is substantial throughout the IPL. 
C) GlyRα3 puncta expression is in a laminar pattern throughout the IPL. D) 
GlyRα4 expression is limited to a distinct band in the upper ON sublamina, yet 
some sparse puncta are seen E) Calbindin (red) Representative confocal image 
of transverse INL, Inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion 
cell layer. Scale bar, 20 μm. (Image from Nobles et al. (2012), J Neuroscience). 
 
In the inner retina, evaluation of the decay kinetics of glycinergic sIPSCs as 
well as immunohistochemistry show that OFF cone and rod BCs express GlyRα1 
and that ON cone BCs have no glycinergic inputs (Figure 1.1) (Eggers et al., 2007; 
Ivanova, Muller, & Wassle, 2006; Majumdar et al., 2007; Wassle et al., 2009). 
Assays of a small subset of morphologically identified ACs indicate differential 
expression of GlyRs. Narrow-field ACs express GlyRα2, AII ACs express either 
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GlyRα3 and/or GlyRα1 (Gill et al., 2006), and starburst ACs (SACs) express 
GlyRα4 and may also express GlyRα2 (Haverkamp et al., 2004; Heinze et al., 
2007; Majumdar et al., 2009; Weiss et al., 2008). In addition, the large soma OFFα 
RGC express only GlyRα1 (C. Zhang et al., 2014).  
Zhang et al. determined that GlyRα1 input on OFFα RGCs helps modulate 
the spontaneous excitatory activity to improve the signal to noise ratio and slightly 
hyperpolarizes the cell reducing the spiking probability. Furthermore, GlyRα1 input 
in OFFα RGCs helps diminish the rebound excitation caused by the transient 
suppression of spiking from ON cone bipolar cells during an OFFset stimulus. 
Finally, OFFα RGCs express GlyRα1, which receives crossover inhibition 
mediated by glycinergic input from the AII amacrine cell during the onset of light. 
Does GlyRα1 have a similar role in other GlyRα1 only expressing RGCs or does 
its role differ based on the retinal ganglion cell response properties? Collectively 
the RGCs with the largest soma diameters only make up about 8% of all RGCs 
expressed in the retina (Sanes & Masland, 2015). Which GlyRs are expressed on 
the other ~92% of RGCs is unknown and a significant gap in our knowledge. 
Furthermore, these cells may express or co-express any of the four different GlyRα 
subunits, and these GlyRs may serve different functions. Using established 
techniques, we intend to further unveil the unique GlyR expression of specific types 
of retinal ganglion cells. 
II. SPECIFIC AIMS 
 
Ramón Y Cajal caricaturized elegant and accurate descriptions of retinal 
cells. These images and descriptions inspired many to investigate and decipher 
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retinal circuitry and the components that facilitate vision. As the previous review 
portrays, we know a great deal about the components and function of the retina. 
Retinal biologists continue to discover new cells types, genes, transcription factors, 
and circuit pathways at a rapid pace. These newly discovered components of the 
retina generate new questions and new gaps in our knowledge. For instance, we 
have limited understanding of the subunit-specific GlyR expression in the RGCs, 
even though we know there is differential expression of all four different GlyRs 
throughout the IPL. Furthermore, subunit-specific glycine receptor function is 
unknown and they could play different roles depending on the specific RGC visual 
response properties. I set out to identify subunit specific GlyR expression in RGCs 
using the following aims. 
Aim 1 – Identify Glycinergic Expression on a Subset of Retinal Ganglion Cells 
 
Aim 1 of my dissertation is to identify and characterize the glycinergic 
expression across nine different RGC types and one displaced amacrine cell. 
Ideally, these ten cell types will collectively include all four glycine receptor 
subunits. First I will examine three of the four RGCs with the largest somas, the 
ONα, ONT, and OFFδ. Together with the previously examined OFFα RGC, these 
RGCs complete a homolog set for major visual response properties- ON/OFF and 
transient/sustained. The glycine alpha subunit receptor expression of OFFα RGCs 
was identified by Zhang et al., and I will verify this finding using a similar assay (C. 
Zhang et al., 2014). I will examine glycine receptor expression in the following other 
retinal cell types: ON starburst amacrine cells, bistratified ON/OFF direction 
selective (ooDS) RGCs, local edge detectors, high definition RGCs, ultra-high 
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definition RGCs, asymmetric F-mini RGCs, and JAMB RGCs. Together, these 
cells represent about 60% of all RGC types in the mouse retina and characterize 
a variety of distinctive morphology and visual response properties. 
Aim 2 - Examine the GlyRα Expression of ooDS RGCs using an rAAV-
Glra4shRNA 
 
Aim 2 of my dissertation is to investigate the glycine receptor expression of 
the ooDS RGC. In the absence of GlyRα2 or GlyRα4, glycinergic sIPSC frequency 
does not change, although in the double knockout of GlyRα2 and GlyRα4 the 
glycinergic sIPSC frequency is almost completely reduced. Thus, a mechanism 
must exist that compensates for the loss of one of the glycine receptors in these 
RGCs. We will use an adeno-associated virus (rAAV) delivered short hair pin RNA 
(shRNA) to knockdown GlyRα4 expression and determine if the glycinergic sIPSC 
frequency decreases. This experiment will indicate if a compensatory mechanism 
exists in the amacrine cells (which will not lose GlyRα4) and if the compensation 
mechanism is present after full development of the synapse. Compensation 
mechanisms could include: an increase in glycine release from the presynaptic 
amacrine cells, due to an overall loss of glycinergic input in the upstream circuit or 
an increase in GlyR expression or trafficking to the postsynaptic site as a 
consequence of differential expression of these glycine alpha subunits during 
development. 
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CHAPTER II 
EXPERIMENTAL MATERIALS AND METHODS 
2.1 Animals 
 
All experiments were carried out in accordance with the Association for 
Research in Vision and Ophthalmology “Statement for the Use of Animals in 
Ophthalmic and Visual Research” and with the approval of the Institutional Animal 
Care and Use Committee of the University of Louisville. The mice were housed in 
a facility at the University of Louisville Health Sciences Center and received daily 
care from the veterinary staff. The mice were kept on a 12-hour light 12-hour dark 
schedule and fed chow ad libitum.  
I used three different single GlyR knockout (KO) mice (Table 2.1) as well as 
crosses between these knockout mice to form double GlyR knockout mice. I used 
reporter mouse lines that express fluorescent proteins in specific retinal ganglion 
cells (RGCs) for experiments to establish the baseline glycinergic responses and 
create hypotheses for which glycine receptors are expressed onto those specific 
ganglion cells (Table 2.1). These reporters were used alone for wild type (WT) 
controls and were also bred to single and double KOs as indicated in Table 2.1. 
To test for loss of glycine receptor function on specific ganglion cells, we used the 
single or double GlyR knockout lines crossed to the reporter lines (Table 2.1).
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Table 2.1. List of Animal Lines Used for Experiments  
Strain name 
Source/Jackson lab 
stock# 
 Cells targeted 
Chapter 
Glra2-/- 
Young-Pearse et al., 2006; 
007065 
 
 
All RGCs 
 
 
III,  
Glra3-/- Harvey et al., 2004; 007065 III 
Glra4-/- Created in our lab III, IV 
 Glra2-/-/3-/- Glra2-/- X Glra3-/- III 
Glra2-/-/4-/- Glra2-/- X Glra4-/- III, IV 
Thy1Stp-EYFP 
Gift of J. Sanes;(Buffelli et al., 
2003); 005630 
Cre expressing cells 
III 
PVCre 
PvalbCre X Thy1Stp-EYFP ; 
(Farrow et al., 2013) 
ooDS RGCs, ONα, 
ONT, OFFα, OFFδ, 
PV4, LED, OFFT,   
F-mini 
III 
Glra2-/-/PVCre Glra2-/- X PVCre III, IV 
Glra3-/-/PVCre Glra3-/- X PVCre III 
Glra4-/ /PVCre Glra4-/- X PVCre III, IV 
Glra2-/-/3-/-/PVCre Glra2-/-/3-/- X PVCre III 
Glra2-/-/4-/-/PVCre Glra2-/-/4-/- X PVCre III, IV 
TRHR-GFP Gift of A. Huberman 
ooDS RGCs 
III, IV 
Glra4-/-/TRHR Glra4-/- X TRHR III, IV 
Glra2-/-/4-/-/TRHR Glra2-/-/4-/- X TRHR III, IV 
ChAT-cre/Ai9 
Gift of W. Guido; ChAT-cre 
(006410) X Ai9(007905) 
 
ON SACs  
 
III 
Glra4-/-/ChAT-cre/Ai9 Glra4-/- X ChAT-cre/Ai9 III 
Glra2-/-/4-/-/ChAT-cre/Ai9 Glra2-/-/4-/- X ChAT-cre/Ai9 III 
TYWY3 Gift of J. Sanes; LED, HD1, HD2, 
UHD  
III 
Glra3-/-/W3 Glra3-/- X W3  III 
TYWY7 Gift of J. Sanes; ONT, OFFα, OFFδ III 
HoxD10-GFP 
Gift of D. Berson; (MMRRC id 
32065) 
 
HoxD10 
III 
Glra2-/-/HoxD10 Glra2-/- X HoxD10  III 
JAMBCreER/STP Gift of J. Sanes; 
JAMB 
III 
Glra4-/-/JAMBCreER/STP Glra4-/- X JAMBCreER/STP III 
Glra2-/-/4-/-/JAMBCreER/STP Glra2-/-/4-/- X JAMBCreER/STP III 
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2.2 Viral Vector Construction and Packaging 
 
To circumvent the problem of using a global knockout to eliminate all of one 
GlyRα subunit and affecting GlyRα subunit expression in bipolar cells and 
amacrine cells, we developed an rAAV delivered method to target just RGCs and 
eliminate their expression of specific GlyRαs using shRNA. Our lab successfully 
demonstrated this method in Zhang et al. 2014 where an rAAV virus was packaged 
with an shRNA that when expressed, knocked down the expression of GlyRα1 only 
in RGCs; the methods used to create this virus were also published in Zhang et al. 
(Fig 2.2A) (Zhang et al., 2014). We used the same plasmid but switched out the 
shRNA target of Glra1 for Glra4. 
We tested a series of four different Glra4 shRNA constructs using cell 
culture, transfection, and immunoblotting. Briefly, Human Embryonic Kidney 
(HEK293T) cells were cultured in high-glucose DMEM supplemented with 10% 
fetal bovine serum, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 µg/ml 
streptomycin. Cells were seeded on 6-well culture plates one day prior to 
transfection and transfected with a GlyRα4 expression plasmid tagged with FLAG 
and Myc, with or without shRNA plasmids, using jetPrime reagent (Polyplus-
transfection, New York, NY) according to the manufacturer’s instructions. Thirty-
six to sixty hours after transfection, cells were harvested in NP-40 lysis buffer 
(50mM Tris, 150mM NaCl, 2mM EDTA, and 1% Nonidet P40, pH 8.0, 
supplemented with protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO)) and 
disrupted by rotating for 45 min at 4°C followed by sonication. Cell debris was 
removed by centrifugation at 17,000 X g for 15 min at 4°C, the supernatant was 
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collected, and protein quantified using the Bradford reagent (Bio-Rad, Hercules, 
CA). Twenty-five µg of total protein lysates were loaded per lane and analyzed on 
4–12% NuPAGE gels (Invitrogen, Thermo Fisher Scientific, Waltham, MA), 
transferred to PVDF membranes and blocked with Odyssey Blocking Buffer (LI-
COR, Lincoln, NE). Membranes were incubated with primary antibodies (rabbit 
anti-Flag, 1:2000 and mouse anti-β-actin; 1:25000) diluted in Odyssey Blocking 
Buffer and washed four times with TBS containing 0.1% tween-20 (TBST). After 
incubating with IRDye800 CW and IRDye680 CW-conjugated secondary 
antibodies diluted in Odyssey Blocking Buffer, membranes were washed four times 
with TBST. Protein bands were visualized by scanning the membranes in an 
Odyssey Infrared Imaging System (LI-COR, Lincoln, NE) using both 700 and 800 
nm channels. β-actin was used as a loading control (Figure. 2.1A-B). 
 We chose the 29mer shRNA-D to insert into the in the pGFP-V-RS vector, 
Origene, Rockville, MD) where the plasmid included: flanking Inverted terminal 
repeats, elongation factor-1 promoter, a tdTomato gene with a nuclear localization 
sequence, woodchuck hepatitis post-transcriptional regulatory element, a 
polyadenylation site to protect the mRNA from degradation, the H1 promoter and 
the Glra4KD-shRNA cassette (Figure 2.1C). The plasmids were packaged into the 
recombinant 2/7 rAAV vector serotype using a standard triple-plasmid protocol by 
co-transfection of HEK293T cells to create the rAAV-Glra4KD-shRNA (Grieger, 
Soltys, & Samulski, 2016; McClements & MacLaren, 2013; Reid & Lipinski, 2018) 
(Fig2.2B). 
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Figure 2.1. Glra4KD-D chosen among four different shRNA candidates 
A) Immunoblots of HEK lysates transfected with Flag-tagged Glrα4 expression in 
each lane with: lane 1, Glrα4 expression alone, lane 2, mock, lanes 3-6 Glra4KD 
shRNA candidates A-D, and lane 7, shRNA negative. Β-actin expression was 
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used as a control. B) Quantified and normalized immunoblot data, note Glrα4 
expression alone was normalized to 100%. All Glra4KD candidates were 
successful, but shRNA-D was chosen due to the demonstration of the least Glrα4 
expression. C) Plasmid map (image from SnapGene Viewer, GSL Biotech, 
Chicago, IL) for pAAV-Ef1a-NLStdtomato-H1-Glra4-shRNA-D, which was used to 
create the rAAV-Glra4KD-shRNA 
2.3 rAAV injection into Major Optic Nerve Targets of the Brain. 
 
Anesthesia was induced by an intramuscular (IM), intraperitoneal (IP) 
injection of a mixture of ketamine (70mg/kg) (VetaKet, Akorn, Lake Forest, IL) and 
xylazine (12mg/kg) (AnaSed, LLOYD, Shenandoah, IA) and to maintain 
anesthesia, an additional booster (50% concentration of the original solution) was 
administered subcutaneously and the dosage and time administered was noted. 
The mouse vibrissae and scalp were shaved. The mouse was placed on a 
temperature feedback-controlled heating pad to maintain body temperature. The 
mouse head was secured in a stereotaxic frame with ear bars and a bite bar. 
Wetting eye drops (1.3% polyvinyl alcohol, OCuSOFT, Rosenberg, TX) were 
applied to both eyes and were covered with small plastic lenses to maintain 
lubrication. A ground wire was inserted subcutaneously above right shoulder. A 
midline incision was made to expose the skull, and a craniotomy was performed 
at 0.5 mm anterior and 0.5 mm temporally left of Lambda over the superior 
colliculus (SC), or at 2.5 mm posterior and 2.5 mm temporally to the left of Bregma 
over the dorsal lateral geniculate nucleus (dLGN). The craniotomies were 2mm by 
2mm in size. To locate the SC or the dLGN a borosilicate glass pipette (inner 
diameter of 40-50 μm) was filled with ~10 µl of Ringer's solution and positioned 
over the craniotomy. The pipette was lowered from the surface of the brain to 
between 1000 µm and 1200 µm for the SC and 2700 µm and 3000 µm for the 
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dLGN. The pipette contained an electrode, which was connected to an FHC Xcell-
3+ microelectrode amplifier (FHC, Bowdoin, ME) and a Grass Instruments AM-10 
audio monitor (Grass Instruments, Warwick, RI). The contralateral eye was 
stimulated with a full field light source, and audible spiking responses from the 
amplifier and monitor were used to verify the tip of the electrode had penetrated 
the SC or dLGN. The depth of the pipette tip was recorded and the exploratory 
pipette was carefully removed. A second pipette with an inner diameter ~20 µm 
was filled with 3.0 µl of the virus solution and positioned over the same coordinates 
as the exploratory pipette. The virus filled pipette was lowered to the recorded 
depth and 2.5 μl of the virus was injected into the SC or dLGN. The pipette was 
slowly removed from the injection site after 10 minutes to ensure the virus solution 
did not flow out of the injection site. 
The mouse was then removed from the stereotaxic and placed on a heating 
pad where its scalp was sutured using a tissue adhesive (VetBond, 3M, St. Paul, 
MN). The animal was given a 100 μl dose of Carprofen (1.25 mg/ml) (Putney, 
Portland, ME) subcutaneously above the shoulder blades. Four weeks post rAAV 
injection, RGCs with tdTomato positive nuclei were targeted in the retina for patch 
experiments. 
2.4 Tissue Dissection and Preparation 
 
Under dim red light and at room temperature, dark-adapted animals were 
euthanized, eyes enucleated, and the lens and cornea were removed leaving the 
eyecup. The retina was carefully removed from the eyecup and incubated in a 
solution of Ringers, collagenase (241 units/ml) and hyaluronidase (34.5nM per ml) 
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(Worthington Biochemicals, Lakewood, NJ) for 10 minutes to break down the 
vitreous attached to the retina. Remaining vitreous was carefully removed and the 
enzyme solution was washed 3 times with fresh oxygenated Ringers. The retinas 
were quartered, each quarter was placed RGC side up onto a coverslip, and a 
harp was placed on top of the retina to hold it in place. The entire apparatus was 
placed into the microscope bath perfused with oxygenated Ringer’s solution and 
kept at 36°C using a preheated Ringer’s source and a feedback temperature 
controlled microscope bath. 
2.5 Electrophysiology Recording of Retinal Ganglion Cells 
 
RGCs were observed using a Nikon Eclipse E600FN microscope with a 
Nikon Fluor 60x water immersion objective with Hoffman Modulation Contrast 
(Nikon, Tokyo, Japan). When targeting RGC somas in the PVCre or TRHR reporter 
line retinas, fluorescent protein-expressing somas were observed using a Lumen 
Dynamics X-Cite Series 120Q lamp. In virus-infected retinas, RGC somas double 
labeled with GFP (green) and tdTomato positive (red) nuclei were targeted. Glass 
electrodes (5-7 MΩ of resistance) were made using Kwik-Fil borosilicate glass 
capillaries (1B150F-4, World Precision Instruments, Sarasota, FL), which were 
pulled using a P-97 Flaming/Brown micropipette puller (Sutter Instruments, 
Novato, CA). The electrodes were filled with an intracellular solution that consisted 
of: (in mM) 12.5 CsCl, 107 CsOH, 107 D-Gluconic Acid, 10 Na+ HEPES, 10 
BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP, 5 lidocaine N-ethyl bromide (QX314-
Br), 2 Lucifer Yellow CH Lithium Salt, 7.5 neurobiotin tracer (pH 7.2 adjusted with 
CsOH).  
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Cell recordings were obtained using an Axon MultiClamp 700B patch clamp 
amplifier (Molecular Devices, San Jose, CA) and the signals were digitized at 10 
kHz using an Axon Digidata 1322A (Molecular Devices, San Jose, CA). Signal 
input and output were monitored and recorded using Axon MultiClamp 700B and 
Clampex 10.2 software (Molecular Devices, San Jose, CA). RGCs were held at 
the reverse cation potential (VHold) of +15 mV (0mV after accounting for the liquid 
junction potential) to determine the GlyRα subunit expression. At this holding 
potential, and under three different pharmacological conditions, I recorded 
spontaneous inhibitory postsynaptic currents (sIPSCs). 
2.6 Pharmacological Manipulations of sIPSCs 
 
To isolate specific RGC activity, the cell could be recorded in three different 
bath conditions: 1) A Control bath solution, which consists of Ringer’s solution (in 
mM) 110 NaCl, 2.5 KCl, 1 CaCl2, 1.6 MgCl2, 10 D-glucose and 22 NaHCO3, 
bubbled with 5% CO2/95% O2, pH 7.4) was used to perfuse the tissue. sIPSCs 
recorded in the control condition include both GABARs and GlyR activity. 2) 
Ringer’s solution containing the GABAR blockers: picrotoxin [20μM] – GABAAR 
antagonist (PTX) & TPMPA [50μM] – GABACR antagonist). The sIPSCs recorded 
in this condition are isolated spontaneous glycinergic sIPSCs. 3) Ringer’s solution 
containing the two GABAR blockers and the GlyR blocker strychnine (STRYCH) 
[10μM] – GlyR antagonist. sIPSCs recorded in this condition would come from an 
inhibitory receptor excluding GABARs or GlyRs. 
2.7 Light Stimulation 
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During patch clamp recordings, I measured light-evoked inhibitory and 
excitatory postsynaptic currents and inhibitory postsynaptic currents using a full-
field light stimulus presented with a light emitted diode (LED) positioned above the 
patched cell. The LED emitted a photopic stimulating luminance of 3.7E03 R* for 
all experiments. The light stimuli protocol consisted of a 30ms light presentation 
followed by a 2 second interstimulus interval followed by a 2 seconds light stimulus. 
A protocol consisted of 5 total presentations with a period of 15.25 seconds in 
between repeats. The responses to the five presentations were averaged and 
analyzed using Clampfit software (Molecular Devices, San Jose, CA). Statistical 
analyses were performed using GraphPad Prism (GraphPad, San Diego, CA). 
2.8 Immunohistochemistry 
 
After patch clamp recording, the pieces of retina with recorded and filled 
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12 
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and 
placed into a 24-well plate. Retina pieces were incubated in blocking solution 
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or 
goat) for 60 minutes. Each retina piece was then reacted with a combination of 
primary antibodies to stain for the either GlyRα1, GlyRα2, GlyRα3, or GlyRα4 or a 
combination of two GlyRαXs, and Lucifer yellow overnight at 4°C (Table 2.2). In 
the case where the Lucifer yellow antibody was not compatible, streptavidin was 
used to stain for the filled cell, but was added with the secondary antibodies. The 
single GlyR antibody or combination of GlyR antibodies were selected based on 
our observed τdecay estimates that we matched with the τdecay estimates from the 
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literature (Table 3.2) (Gill et al., 2006; Majumdar et al., 2007; Majumdar et al., 
2009; Veruki et al., 2007; Wassle et al., 2009) The primary antibodies were washed 
off by a series of washes with PBX. Afterwards, a combination of secondary 
antibodies and Hoechst stain (or also streptavidin) in normal serum was added to 
label the primary antibodies and it was left on the tissue overnight at 4°C (Table 
3.2). The Hoechst stain was used to label the DNA in the somas and distinguish 
between the retina nuclear and plexiform layers. The tissue was then washed with 
PBS and mounted onto a slide and covered using VECTASHIELD (Vector Labs, 
Burlingame, CA) clear mounting medium and a coverslip. 
 
Table 2.2. List of Antibodies Used for Immunohistochemistry Experiments  
Ab host / type Target CONC. Manufacturer Catalog No. 
mouse monoclonal 1° GlyRα1 1:500 Synaptic systems Cat # 146 111 
goat polyclonal 1° GlyRα2 1:50 Santa Cruz Biotech. Cat #SC17279 
rabbit polyclonal 1° GlyRα3 1:100 Chemicon Cat# AB5472 
rabbit polyclonal 1° GlyRα4 1:100 Chemicon  Cat# AB9696 
Rabbit polyclonal 1° Lucifer yellow 1:1000 ThermoFisher Cat# A-5750 
donkey / Alexa 555 2° anti-mouse 1:200 Life Technologies Cat# A31570 
donkey / Cy3 2° anti-goat 1:200 JAX ImmunoResearch  Cat# 115165003 
goat / Cy3 2° anti-mouse 1:200 JAX ImmunoResearch Cat# 111165003 
goat / Cy3 2° anti-rabbit 1:200 JAX ImmunoResearch Cat# 705165003 
DAPI (Vectashield) DNA cong. 1.5 μg/ml Vector Laboratories Cat# H-1500 
Hoescht DNA cong. 1:1000 Life technologies  Cat# H3570 
 
The recorded and filled RGCs in the mounted tissue were imaged using an 
Olympus FV1000 confocal microscope. Whole RGC images were acquired using 
a 40x water immersion (NA 1.15) objective, and dendrites and puncta expression 
were acquired using a 60x oil immersion objective (NA 1.4). Images were recorded 
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with Fluoview software (Olympus, Tokyo, Japan). The depths of the RGC’s 
dendritic ramifications were measured relative to the top of the GCL and the bottom 
of the INL. Combining a RGC’s dendritic ramification depth, dendrite arbor 
diameter, and light response help identify and verify specific RGC types. 
2.9 Electrophysiology Recording Analysis 
 
The Mini Analysis program (Synaptosoft, Decatur, GA) was used to identify 
sIPSCs and determine their decay time constant “τ.” In raw recordings, an sIPSC 
was defined as a waveform whose peak exceeded twice the root mean squared 
(RMS) of the noise in the system (the noise in our system was usually between 1.5 
and 5.0 pA). Single sIPSCs were detected from a template that had and a fast 
monotonic rise time to a single peak, and an exponential decay (Figure 1.5). The 
10-90% rise time, and frequency of these sIPSCs were measured and their decay 
kinetics were estimated from a least-square fit of 10-90% of the decay phase, using 
a single exponential decay function. The goodness of fit was determined by 
comparing to a least-square fit of 10-90% of the decay phase a single to a double 
exponential function. All of the sIPSCs included in further analyses met these 
criterion and were used to calculate the average decay tau (τdecay), again using a 
single exponential fitting to a least-square fit of 10-90% of the decay phase (Figure 
1.5). Only sIPSCs that represented isolated events were used to calculate the 
τdecay of glycinergic sIPSCs. The τdecay of the average glycinergic sIPSC from each 
cell was also fit to both a single exponential and a double exponential. The R 
squared values for the single and double exponentials were always similar, 
indicating the single exponential was a sufficient fit to the average sIPSC. The 
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sIPSC τdecay data was plotted in cumulative frequency distributions, frequency 
distributions, and average sIPSC τdecay per cell. These τdecay distributions were 
compared across cells classes in WT, KO, and injected animals using the 
Kolmogorov–Smirnov test. The number of sIPSCs measured in 100sec was used 
to determine the frequency of sIPSCs/sec for each cell. The mean frequencies for 
each cell type were compared across other cell classes in WT, KO, and injected 
animals using a one-way ANOVA with a Bonferroni post-hoc test. 
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CHAPTER III 
EXPRESSION OF DISTINCT GLYCINE RECEPTOR SUBUNITS IS FOUND 
ACROSS IDENTIFIED RETINAL GANGLION CELL TYPES 
INTRODUCTION 
 
The retina is a laminar structure with each layer populated by specific 
classes of neurons. The vertical connections among these cells across layers form 
a variety of parallel circuits that encode the visual scene into electrical signals. The 
retinal ganglion cells (RGCs) represent the culmination of this signaling and their 
output forms the substrate for vision throughout the rest of the brain. There are 
about 40 different RGCs and they are defined by their genetic makeup, 
morphology, and visual responses (Baden et al., 2016; Bae et al., 2018; Masland, 
2001; Sanes & Masland, 2015). The differences in the responses across the 
different types of RGCs arise from direct, feedforward inhibition as well as many 
forms of inhibition that modulate their excitatory input (Franke et al., 2017; 
Masland, 2012; Sanes & Masland, 2015; Werblin, 2011). Unlike most other areas 
of the CNS, the retina utilizes both GABA and glycine neurotransmitters and 
receptors in inhibitory processing (Franke & Baden, 2017; Werblin, 2011; C. Zhang 
et al., 2015).  
Where GABA receptors are heteropentamers composed of a combination 
of five of 17 different subunits (α, β, γ, δ, and ρ subunits) glycine receptors 
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(GlyRs) have a simpler composition (Bormann, 2000; Yang, 2004). Retinal GlyRs 
are heteropentamers with three of the same β subunits and two of the same α 
subunits, in a stoichiometry of 3β:2α. (Betz & Laube, 2006; Grudzinska et al., 2005; 
Nobles et al., 2012). There are four different α subunits (α1, α2, α3, and α4) that 
underlie four different GlyRs isoforms: GlyRα1, GlyRα2, GlyRα3, and GlyRα4 
(Dutertre et al., 2012; Wassle et al., 2009). The rise time of the glycinergic sIPSCs 
across the four GlyRs is similar; the 10% to 90% of peak rise time ranges between 
1 and 3ms (Wassle et al., 2009; Weiss et al., 2008). In contrast, the decay kinetics 
(τdecay) of GlyR sIPSCs mediated by the four isoforms differs. At room temperature 
their decays have been measured as: fast GlyRα1 (2-4 ms), medium GlyRα3 
(~10ms) to slow GlyRα2 and GlyRα4 (20-40 ms) (Lynch, 2004; Majumdar et al., 
2007; Majumdar et al., 2009). 
In the mature spinal cord, brain stem, and sub-cortical regions, GlyRα1 is 
the primary glycinergic isoform with GlyRα3 expressed to a lesser extent (Lynch, 
2004, 2009). In contrast, all four α subunit isoforms are expressed in the retina. 
The pattern of expression of each of the GlyRs differs across the inner plexiform 
layer (IPL) (Nobles et al., 2012; Wassle et al., 2009). Both the expression of these 
subunits and their pattern of expression is conserved across a broad range of 
species such as zebrafish to non-human primates (David-Watine et al., 1999; 
Harvey et al., 2000; Leacock et al., 2018; Matzenbach et al., 1994). GlyRα1 
expression is found throughout the IPL, with its densest expression in the OFF 
sublamina, where it is localized on the OFF cone bipolar cells (Haverkamp et al., 
2004; Nobles et al., 2012). GlyRα2 expression is dense and uniform throughout 
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the IPL (Haverkamp et al., 2004; Nobles et al., 2012). GlyRα3 is expressed in three 
distinct lamina across the IPL and it has been suggested this pattern indicates 
GlyRα3 is involved in different glycinergic circuits (Haverkamp et al., 2003; 
Haverkamp et al., 2004; Nobles et al., 2012). GlyRα4 is expressed in a thin band 
along the top of the ON sublamina of the IPL and co-localizes with the ON Choline 
Acetyltransferase (ChAT) band associated with ON starburst amacrine cells 
(SACs) (Heinze et al., 2007; Nobles et al., 2012).  
Subunit specific GlyR expression has been identified in several retinal cell 
classes. OFF cone and rod bipolar cells express GlyRα1 (Eggers et al., 2007; 
Haverkamp, 1995; Sassoe-Pognetto, Wassle, & Grunert, 1994). Some subsets of 
the narrow-field cells, such as AC type 5/6 and type 7 express GlyRα2 (Majumdar 
et al., 2009; Weiss et al., 2008). But this is not the rule, AII amacrine cells, which 
also are narrow-field, express GlyRα3 and possibly GlyRα1 (Demb & Singer, 2012; 
Gill et al., 2006; Majumdar et al., 2009; Weiss et al., 2008), and the GABAergic 
wide-field SACs express GlyRα4 (Haverkamp et al., 2004; Majumdar et al., 2007; 
Weiss et al., 2008). Among the αRGCs, GlyRα1 is expressed by OFFα RGCs 
(Majumdar et al., 2007; Sun, Li, & He, 2002; Veruki et al., 2007; C. Zhang et al., 
2014). This then suggest that GlyRα subunit specific inhibition is diverse across 
retinal cell types and because of their different decay kinetics could represent 
additional diversity of inhibitory processing that is likely to influence visual 
processing.  
To begin to expand our view of the role glycine subunit specific inhibition, 
we characterized the rise and decay kinetics of GlyRα mediated synaptic events, 
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e.g., glycinergic spontaneous inhibitory postsynaptic potentials (sIPSCs) in eight 
identified wild type (WT) RGC types. In addition, we examined GlyRα subunit 
specific expression, using immunohistochemistry. Based on these characteristics, 
we formulated hypotheses about the composition of GlyRα subunits in each of 
these eight RGCs types. We tested our ideas by altering GlyRα subunit specific 
expression, using global GlyRα2, 3 or 4 knockout (KO) mice and retrogradely 
transported rAAV shRNA to knockdown expression of GlyRα subunits within 
mature RGCs.  
 We found significant GlyRα subunit diversity across identified RGCs. Like 
OFFα RGCs, the other three α RGCs (those with the largest somas/dendritic 
arbors) also expressed GlyRα1 (Farrow et al., 2013; Krieger, Qiao, Rousso, 
Sanes, & Meister, 2017; Majumdar et al., 2007; Sanes & Masland, 2015). In 
contrast, the other six RGC types that we studied (e.g., local edge detectors, high 
definition, ultra-high definition, F-mini OFF transient, Junction adhesion molecule 
“B” (J-RGCs) (Jacoby & Schwartz, 2017; Liu & Sanes, 2017; Rivlin-Etzion et al., 
2011; Rousso et al., 2016; Sanes & Masland, 2015) as well as the ON SACs 
expressed two different GlyRαs. In some, the decay kinetics were similar (both fast 
or both slow) and in other RGCs, the decay kinetics differed (one fast and one 
slow). Thus, GlyR diversity is likely to be the basis for enhanced subunit specific 
inhibition in the modulation of RGC visual responses.  
MATERIALS AND METHODS 
 
Animals 
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We used cell type specific mouse reporter lines to target RGCs for these 
analyses (Table 1). All experiments followed the ARVO Statement for the Use of 
Animals in Ophthalmic and Visual Research and were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Louisville. We 
induced GFP expression in JAM-B-CreER mice by daily intraperitoneal injections 
of 100 μl of 20 mg/ml tamoxifen solution (100mg of tamoxifen (Sigma-Aldrich, St. 
Louis, MO) in 5 ml corn oil) for three days. 
 
Table 3.1. List of Animal Lines and their Labeled Cells Used for Experiments 
Mouse line KO crosses cell types labeled References 
B6-
Pvalb tm1(cre)Arbr/J/Thy1STP-
EYF P(PvCre/Thy1STP) 
Glra2-/-, Glra3-/-, 
Glra4-/-, Glra2-/-
/Glra3-/-, Glra2-/-
Glra4-/- 
ONα, ONTrans, OFFα, 
OFFδ, ooDS RGC,  
Hippenmeyer et al. 2005, 
Zhang et al. 2014 Farrow et 
al., 2013 
TYW7  OFFα, OFFδ (I. J. Kim, Zhang, Meister, & 
Sanes, 2010) 
TYW3 (W3) Glra3-/- LED, HD1, HD2, UHD (Jacoby & Schwartz, 2017; I. 
J. Kim, Zhang, Meister, & 
Sanes, 2010; Y. Zhang, Kim, 
Sanes, & Meister, 2012 
ChAT-cre/Ai9 Glra2-/-, Glra4-/-, 
Glra2-/-/Glra4-/- 
Displaced ON starburst 
amacrine cell 
ChAT-cre (Jackson 
Laboratory) (Rossi et al., 
2011) Ai9 (Allen Institute) 
JAM-B-CreER Glra2-/-, Glra2-/-
/Glra4-/- 
Intrinsically asymmetric 
orientation selective 
RGCs 
(Liu & Sanes, 2017) 
  
Viral Vector Construction and Production 
Methods to create the rAAV-Glra1-shRNA have been published (Zhang et 
al 2014), and are briefly described here. Serotype 2/7 recombinant rAAVs were 
made using a standard triple-plasmid protocol by a transient co-transfection of an 
vector plasmid, rAAV helper plasmid (harboring Rep/Cap), and Ad-helper plasmid 
(pGHTI-adeno1) into HEK293T cells. The rAAV vector plasmid was a pGFP-V-RS 
vector, Origene, Rockville, MD), which included: flanking Inverted terminal repeats, 
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elongation factor-1 promoter, a tdTomato gene with a nuclear localization 
sequence, woodchuck hepatitis post-transcriptional regulatory element, a 
polyadenylation site to protect the mRNA from degradation, the H1 promoter and 
the 21mer Glra1-shRNA cassette (Figure 1). The transfected cells were cultured 
in high-glucose DMEM supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 50 IU/ml penicillin, and 50 µg/ml streptomycin. The packaged rAAVs 
were concentrated and purified from the total cell lysate using iodixanol gradient 
centrifugation and collected in the 40% iodixanol band. Genome copy number 
titration was evaluated using RT-PCR (Applied Biosystems, TaqMan reagents). 
The titer of the rAAV-Glra1-shRNA was 3.5 X 1012 vg/ml. 
Viral Injections in the Dorsal Lateral Geniculate Nucleus or Superior Colliculus  
Methods to inject virus into the dLGN have been published (C. Zhang et al., 
2014) and also are described briefly. In addition, we also injected virus into the 
superior colliculus (SC), using a similar approach. Mice were anesthetized, placed 
on a feedback controlled heating pad to maintain body temperature at ~ 36°C and 
their heads were secured in a stereotaxic with ear cups and a bite bar. Eyes were 
lubricated with 1.3% polyvinyl alcohol and the corneas protected from dehydration 
with plastic contact lenses. All injections used stereotaxic coordinates (Paxinos & 
Franklin, 2004) to locate the craniotomy over either the dLGN or the SC. For SC 
injections, a midline incision was made in the skin over the skull, and a craniotomy 
was performed at 0.5 mm anterior and 0.5 mm temporal to Lambda. A borosilicate 
glass pipette (interior diameter of 40-50μm), filled with ~10 µL of Ringer's solution, 
was positioned over the craniotomy and lowered between 800µm and 1200µm 
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from the surface. The dLGN or SC was located by recording visually evoked 
spiking activity as the pipette was lowered. The depth was recorded where clear 
visually evoked responses were obtained and the Ringer’s pipette was removed. 
A second pipette (interior diameter of 18-22 µm), filled with 3.0 µL of virus was 
positioned at the same stereotaxic coordinates as the Ringer’s filled pipette and at 
the same depth. Light-evoked responses also were used to refine pipette 
placement. Using light pressure, 2-2.5μL of virus was injected into the SC. Mice 
were recovered from anesthesia, the incision was closed with skin glue (VetBond, 
3M, St. Paul, MN) and the animal was given a subcutaneous 100 μl dose of 
Carprofen (1.25 mg/ml) (Putney, Portland, ME). Four weeks post injection, retinas 
were dissected, quartered, and mounted for whole cell patch clamp. 
Immunohistochemistry 
After patch clamp recording, the pieces of retina with recorded and filled 
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12 
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and 
placed into a 24-well plate. Retina pieces were incubated in blocking solution 
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or 
goat) for 60 minutes. Each retina piece was then reacted with a combination of 
primary antibodies to stain for the either GlyRα1, GlyRα2, GlyRα3, or GlyRα4 or a 
combination of two GlyRαXs, and Lucifer yellow overnight at 4°C (Table 1). In the 
case where the Lucifer yellow antibody was not compatible, streptavidin was used 
to stain for the filled cell, but was added with the secondary antibodies. The single 
GlyR antibody or combination of GlyR antibodies were selected based on our 
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observed τdecay estimates that we matched with the τdecay estimates from the 
literature (Table 3.2) (Gill et al., 2006; Majumdar et al., 2007; Majumdar et al., 
2009; Veruki et al., 2007; Wassle et al., 2009) The primary antibodies were washed 
off by a series of washes with PBX. Afterwards, a combination of secondary 
antibodies and Hoechst stain (or also streptavidin) in normal serum was added to 
label the primary antibodies and left on the tissue overnight at 4°C (Table 3.2). The 
Hoechst stain was used to label the DNA in the somas and distinguish between 
the retina nuclear and plexiform layers. The tissue was then washed with PBS and 
mounted onto a slide and covered using Vectashield (Vector Labs, Burlingame, 
CA) clear mounting medium and a coverslip. 
 
Table 3.2. Primary and Secondary Antibodies used for Immunohistochemistry 
Ab host / type Target CONC. Manufacturer Catalog No. 
mouse monoclonal 1° GlyRα1 1:500 Synaptic systems Cat # 146 111 
goat polyclonal 1° GlyRα2 1:50 Santa Cruz Biotech. Cat #SC17279 
rabbit polyclonal 1° GlyRα3 1:100 Chemicon Cat# AB5472 
rabbit polyclonal 1° GlyRα4 1:100 Chemicon  Cat# AB9696 
Rabbit polyclonal 1° Lucifer yellow 1:1000 ThermoFisher Cat# A-5750 
donkey / Alexa 555 2° anti-mouse 1:200 Life Technologies Cat# A31570 
donkey / Cy3 2° anti-goat 1:200 JAX ImmunoResearch  Cat# 115165003 
goat / Cy3 2° anti-mouse 1:200 JAX ImmunoResearch Cat# 111165003 
goat / Cy3 2° anti-rabbit 1:200 JAX ImmunoResearch Cat# 705165003 
Hoescht DNA cong. 1:1000 Life technologies  Cat# H3570 
Streptavidin-Cy2 Neurobiotin 1:1000 JAX ImmunoResearch Cat# 016220084 
 
Confocal Image Acquisition and Colocalization Analysis  
We imaged the filled RGCs, using an Olympus Fluoview FV1000 confocal 
microscope with Fluoview software (Olympus, Tokyo, Japan) and characterized 
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their soma and dendritic morphology. The depths of the RGC's dendritic 
ramifications were measured relative to the top of the RGC layer and the bottom 
of the INL. The dendritic arbor diameter was measured using the polygon 
measurements tool in the Fluoview software. Each RGC's dendritic ramification 
depth, dendritic arbor diameter, and light response were used to identify the 
specific RGC type. Individual dendrites and puncta expression were imaged with 
a 60x oil immersion objective (NA 1.4). 
Expression of individual GlyRα subunits was evaluated using Imaris 
software (Bitplane, Zurich, CH) on filled RGCs after immunohistochemical 
reactions. To improve the sensitivity of our image analysis, images of cell dendrites 
and GlyR puncta were deconvolved using constrained iterative deconvolution in 
cellSens (Olympus, Tokyo, Japan). GlyR puncta (color channel 1) coincident on or 
within dendritic processes (color channel 2) were counted and the length of the 
dendritic process was measured using the Filaments tool. The counting process 
was performed using one of two methods. The Imaris puncta co-localization tool 
was used to count the puncta for the: ONα RGCs, ONTransient RGCs, OFFδ RGCs, 
the GlyRα3 expression on the F-mini RGCs, and the ON SACs. The Imaris 
surfaces (to identify puncta) and surface to filament co-localization tools were used 
to count puncta on the: LED, UHD, HD, and for the expression measurement of 
GlyRα2 on the F-mini RGCs.  To determine specificity of the coincident puncta, 
the puncta channel (channel 1) was rotated along its x/y axis and coincident GlyR 
puncta were recounted. The “rotated” puncta represent an estimate of coincident 
expression, i.e. puncta not expressed on the dendrite of the filled cell. The original 
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puncta count was compared to the random puncta count using a one-tailed paired 
t-test to verify positive puncta expression on the dendrite. Finally, the rotated 
coincident puncta was subtracted from the “original” puncta density to provide an 
estimate of “corrected” puncta density.  
Whole Mount Retinal Preparation for Electrophysiological Recordings 
 
Animals were dark adapted for 30 minutes, given an IP injection of a cocktail 
of ketamine and xylazine, and sacrificed using cervical dislocation. The eyes were 
enucleated, the front of the eye removed and the retinas dissected under dim red 
light at room temperature. The retina was incubated in a solution of Ringer’s with 
collagenase (241 units/mL) and hyaluronidase (34.5nM per mL) (Worthington 
Biochemicals, Lakewood, NJ) for 10 minutes to break down and remove the 
vitreous attached to the retina. Remaining vitreous was carefully removed and 
retinas were washed 3 times with fresh oxygenated Ringers to eliminate the 
enzymes. Retinal whole mounts were quartered and each piece was placed RGC 
side up onto a cover slip and placed into an oxygenated chamber until used. To 
record from RGCs, a harp was placed on top of the retina to stabilize it and the 
coverslip was placed into a chamber (Cell MicroControls, Norfolk, VA) on the stage 
of the microscope. Wholemounts were continuously bathed in an oxygenated 
Ringer’s solution at 36°C. The Ringer’s solution was preheated to 36o and the exact 
temperature in the chamber controlled by a feedback controller (Cell 
MicroControls, Norfolk, VA) in the chamber. 
Electrophysiology and Pharmacology 
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Recordings were performed under light-adapted conditions. Either GFP 
fluorescent RGCs, or GFP fluorescent RGCs with rAAV infected nuclei, positive 
for tdTomato expression, were targeted for whole cell patch recordings to record 
spontaneous inhibitory postsynaptic currents (sIPSCs). Oxygenated Ringer’s bath 
solution (in mM: 125 NaCl, 2.5 KCl, 2.0 CaCl2, 1.0 MgCl2, 20 D-glucose, and 1.25 
NaH2PO4, and 26 NaHCO3) (Sigma-Aldrich, St. Louis, MO) was held at 36°C using 
an NBD TC2 BIP (Bipolar) temperature controller (Cell MicroControls, Norfolk, VA). 
The intracellular pipette solution consisted of (in mM: 12.5 CsCl, 107 CsOH, 107 
D-Gluconic Acid, 10 Na+ HEPES, 10 BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP). 
The solution also contained either (in mM: 2.2 Lucifer yellow or 12.4 neurobiotin), 
which labelled the RGC’s complete dendritic arbor morphology. After obtaining a 
gigaohm seal, the membrane was broken with swift negative pressure and the 
membrane potential (VHold) was held at -60 mV. All recordings were sampled at 10 
kHz and were filtered using a 4-pole Bessel filter. 
 Holding the RGC membrane potential at +15 mV (0mV after correcting for 
the liquid junction potential), the reversal potential for cations, we isolated and 
recorded inhibitory sIPSCs for 100 seconds in control Ringer’s solution. The RGC 
membrane potential was stepped to -60 mV and GABAA and GABACR antagonists 
(picrotoxin (PTX) [20 μM], and (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphonic 
acid (TPMPA) [50 μM], respectively) were added to the bath solution (Ringer’s) for 
ten minutes. The RGC membrane potential was stepped back to +15 mV and 
isolated glycinergic sIPSCs were recorded for 100 seconds. At the end of this 
recording, we added the GlyR antagonist (strychnine (STRYCH) [10 μM]) to the 
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bath with the GABA antagonists for 5 minutes, recorded residual sIPSCs for 100 
seconds to verify if all sIPSCs were eliminated.  
Visual Stimulation  
Immediately after a whole cell configuration was achieved, we determined 
the visually evoked responses of the RGC using a full field light stimulus. From this 
response we classified RGCs as ON, OFF or ON/OFF where the cell responded 
to the ONset of the light stimulus, the OFFset of the light stimulus, or both.  
Electrophysiological Analysis 
We used Mini Analysis software (Synaptosoft, Decatur, GA) to identify 
sIPSCs and quantify their frequency, rise time, amplitude, and τdecay from 100 
second long voltage clamp recordings of ooDS RGCs held at the reverse cation 
potential. We first selected candidate sIPSC peaks whose amplitude exceeded a 
minimum threshold of twice the root mean squared (RMS) of the noise in each 
recording. The noise was usually between 1.5 and 5 pA. Each sIPSC that met this 
criterion was then evaluated using a model that has a fast rise time (10-90% peak, 
1-6 ms), a single peak, and a single exponential decay time (peak to 37% of peak 
(D37), 2-120 ms). Each sIPSC that fit this model was counted as a sIPSC. From 
this analysis, the frequency of glycinergic sIPSCs is calculated by the software 
over the duration of the 100 second recording. Subsequently, isolated individual 
glycinergic sIPSCs, with single peaks only, were examined and the τdecay and rise 
time of each sIPSC were measured using a single exponential. Double or multi-
peaked sIPSCs were only in included in the frequency data since they cannot be 
reliably measured for τdecay or rise time. The data of the sIPSCs from each cell was 
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grouped with like cells and pharmacological conditions. The τdecay times of the 
sIPSCs of these groups were compared using the Kolmogorov–Smirnov test. The 
mean τdecay, rise time, frequency, and amplitude data of the sIPSCs of these 
groups were compared using a one-way Analysis of Variance, with a Bonferroni 
Post-Hoc test to compare the data for each cell type or the pharmacological 
condition or genotype in which it was recorded. 
RESULTS 
 
All α RGCs (ONα, OFFα, OFFδ, and ONT) Express GlyRα1 
Previously, we and others observed GlyRα1 mediated sIPSCs and 
expression in OFFα RGCs (Zhang et al., Majumdar et al., 2007). We targeted 
GFP+ cells (in PVCre/Thy1STP or W7 retinas) (Farrow et al., 2013; Sanes & 
Masland, 2015) whose soma diameters were > 15μm and characterized their 
GlyRα isoform-specific currents. Both reporter retinas contain GFP+ OFFα, ONα 
and ONδ RGCs and the PVCre/Thy1STP reporter retina, also contains GFP+ ONTrans 
(ONT) RGCs (Krieger et al., 2017). We confirmed our previous observation that 
WT OFFα glycinergic sIPSCs have a mean decay time (τdecay) of 2.6±0.1ms 
(OFFα, N= 15) (C. Zhang et al., 2014) (Figure 3.1A-E). 
All of the characteristics of the glycinergic sIPSCs in the four α RGCs were 
similar (Figure 3.1; One-way Analysis of Variance, Bonferroni Post-Hoc tests). The 
mean τdecay of glycinergic sIPSCs (Figure 1.1 B-E) were: 3.0±0.2 ms (ONα, N = 8), 
2.9±0.2 ms (ONT, N = 10), and 2.7±0.2 ms (OFF𝛿, n = 8) (Figure 3.1D; p > 0.05). 
The mean frequency of glycinergic sIPSCs were: 24.2±2.5 (ONα), 27.5±3.6 (ONT), 
28.1±2.4 (OFFα), and 26.4±5.3 events/sec (OFF𝛿) (Figure 3.1F; p > 0.05). The 
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mean glycinergic sIPSC amplitudes were similar: 42.7±6.0 (ONα), 52.1±10.0 
(ONT), 69.6±14.3 (OFFα), and 87.4±18.0 pA (OFF𝛿) (Figure 3.1G; p > 0.05). The 
mean glycinergic sIPSC rise times were similar: 1.7±0.2 (ONα), 1.3±0.2 (ONT), 
1.7±0.3 (OFFα), and 1.9±0.3 ms (OFF𝛿) (Figure 3.1H; p > 0.05). Thus, we 
hypothesized that ONα, ONT, OFFα, and OFF𝛿 RGCs express only GlyRα1. 
 
Figure 3.1. In WT RGCs with the largest soma diameters Glycinergic sIPSCs are 
fast and mediated by GlyRα1 A) Raw traces of glycinergic sIPSCs of ONα, ONT, 
OFFα, and OFFδ RGCs in the presence of PTX and TPMPA to isolate GlyR-
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mediated sIPSCs. The “ * ” indicates a glycinergic sIPSC. B) Average traces of 
glycinergic sIPSCs of ONα, ONT, OFFα, and OFFδ RGCs. C) Cumulative 
distribution of glycinergic sIPSC τdecay times (ms) for ONα, ONT, OFFα, and OFFδ 
RGCs. The cumulative distributions among the different cell types were similar 
(Kolmogorov–Smirnov test p < 0.05). D) The Mean glycinergic sIPSC τdecay for 
ONα, ONT, OFFα, and OFFδ RGCs were all similar (p > 0.05, One-Way Analysis 
of Variance, Bonferroni Post-Hoc test) E) Frequency distribution of glycinergic 
sIPSC τdecay times indicating a similar distribution among the ONα, ONT, OFFα, 
and OFFδ RGCs. F) Mean glycinergic sIPSC frequency (events/sec) for was 
similar among the ONα, ONT, OFFα, and OFFδ RGCs, (p > 0.05, One-Way 
Analysis of Variance, Bonferroni Post-Hoc test). G) The Mean glycinergic sIPSC 
amplitude among the ONα, ONT, OFFα, and OFFδ RGCs was similar (p > 0.05, 
One-Way Analysis of Variance, Bonferroni Post-Hoc test). H) Mean glycinergic 
sIPSC rise time was similar among the ONα, ONT, OFFα, and OFFδ RGCs (p > 
0.05, One-Way Analysis of Variance, Bonferroni Post-Hoc test). 
 
To validate our recording results, we assessed GlyRα1 immunoreactivity on 
the dendrites of ONα, ONT, OFFα, and OFF𝛿 RGCs. We measured the GlyRα1 
puncta that colocalized with the dendrites of OFFα RGCs and confirmed our results 
0.27±0.03 puncta∙μm-1 (OFFδ, N= 4 cells n=8 areas, data not shown) previously 
published results (C. Zhang et al., 2014). The average GlyRα1-positive puncta 
density on OFFα RGCs was similar to 0.3±0.03 (ONα, N=8, n=15), 0.14±0.02 
(ONT, N=8, n=12), and 0.2±0.02 puncta∙μm-1 (OFF𝛿, N=9 n=16) (Figure 3.2C). We 
estimated randomly associated GlyRα1-positive puncta and compared that density 
to the original co-localized puncta and found that the randomly associated puncta 
were significantly lower for each α RGC type (Figure 3.2C; p < 0.001). Finally, we 
estimated the puncta density by subtracting random from co-localized puncta and 
these also were similar across α RGCs: 0.15±0.02 (ONα, N=2, n=4), 0.09±0.02 
(ONT, N=2, n=3), and 0.13±0.01 puncta∙μm-1 (OFF𝛿, N=2, n=4) including the 
previously reported 0.21±0.2 puncta∙μm-1 (OFFα; (C. Zhang et al., 2014). These 
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results are consistent with our electrophysiological recording and verify that only 
GlyRα1 mediated glycinergic input is at αRGC synapses.  
 
Figure 3.2. RGCs with the largest soma diameters Express GlyRα1. Ai-Aiii) 
Wholemount images of ONα, ONT, and OFFδ RGCs filled with neurobiotin (scale 
bar: 40μm). Bi-Biii) Wholemount images of ONα, ONT, and OFFδ RGC dendrites 
stained for GlyRα1 expression (red) (Images and data sourced from (C. Zhang, 
2015) (scale bar: 5μm). White arrows indicate representative co-localization of 
GlyRα1. Ci-Ciii) Dendrites in WT ONα, ONT, and OFFδ RGCs have significantly 
more GlyRα1 puncta density co-localization (μm-1) in the original (ORI) 
orientation than coincidence co-localization in the flipped (RAN) orientation 
(Wilcoxon Matched-pairs T-test). The corrected puncta density for these cells: 
ONα is 0.15±0.02 μm-1, ONT is 0.09±0.02 μm-1, and OFFδ is 0.13±0.01 μm-1. 
 
rAAV-Mediated RNAi Eliminates GlyRα1-Mediated sIPSCs in rAAV-Glra1-shRNA 
Infected Α RGCs 
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We used our successful knockdown approach (Zhang et al., 2014) to verify 
our observations that all four α RGCs expressed only GlyRα1. We recorded 
glycinergic sIPSCs in α RGCs infected with rAAV-Glra1-shRNA (Zhang et al., 
2014) to knockdown (KD) GlyRα1 expression and compared frequency in WT to 
KD α RGCs. Representative recordings of GABAergic and glycinergic sIPSCs in 
control solution are illustrated in Figure 3.3Ai and their absence is show when the 
GABAergic antagonists PTX and TPMPA were added to the bath (3.3Aii). Virtually 
no glycinergic sIPSCs remained in rAAV-Glra1-shRNA infected α RGCs was: 
0.7±0.2 events/sec (ONα, N = 6), 0.9±0.2 events/sec (ONT, N = 9), 2.3.1±0.4 
events/sec (OFFα, N = 6), and 1.2±0.4 events/sec (OFF𝛿, N = 4) (Figure 3.3B). 
On average the reduction in sIPSCs was (97.2% reduction (ONα), 96.8% (ONT), 
90.4% (OFFα), and 96.3% (OFFδ) (Figure 3.3A,B). These results show that ONα, 
ONT, OFFα, and OFF𝛿 RGCs express only GlyRα1. Furthermore, the OFFα results 
are similar to those found in (C. Zhang et al., 2014) where a ~95% reduction in 
glycinergic sIPSC activity was found in the rAAV-Glra1-shRNA infected OFFα 
RGCs. 
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Figure 3.3. rAAV-Glra1-shRNA knocks down GlyRα1 expression in alpha and 
delta RGCs. Ai) Raw traces of total sIPSCs of rAAV-Glra1-shRNA infected ONα, 
ONT, OFFα, and OFFδ RGCs. Aii) Raw traces of glycinergic sIPSCs in rAAV-
Glra1-shRNA infected ONα, ONT, OFFα, and OFFδ RGCs recorded in the 
presence of TPMPA and PTX. The vast majority of glycinergic activity is depleted 
in these infected RGCs. Aiii) Raw traces recorded in rAAV-Glra1-shRNA infected 
ONα, ONT, OFFα, and OFFδ RGCs in the presence of PTX/TPMPA/STYCH – no 
sIPSCs were observed. The vast majority of glycinergic activity is depleted in 
these infected RGCs. B) The mean glycinergic sIPSC frequency of both 
uninfected and infected ONα, ONT, OFFα, and OFFδ RGCs. The mean infected 
   sIPSCs GlyR sIPSCs   No sIPSCs 
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RGC glycinergic sIPSC frequency was significantly less than the mean 
uninfected RGC counterpart (***p < 0.0001, One-Way Analysis of Variance, 
Bonferroni Post-Hoc test) 
 
rAAV-Mediated RNAi Eliminates GlyRα1 Puncta Expression in Infected α RGCs 
 
To validate the knockdown of Glra1 expression, we quantified coincident 
GlyRα1 puncta on the dendrites of rAAV-Glra1-shRNA infected α RGCs (Figure 
3.3A,B). When compared to uninfected PVCre/Thy1STP α RGCs, the rAAV-Glra1-
shRNA infected RGCs showed significantly lower puncta density (Figure 3.4B, p < 
0.02, Unpaired Mann-Whitney Test). When corrected for chance coincidence, 
there were very few GlyRα1-immunoreactive coincident puncta on the dendrites. 
The average corrected GlyRα1 puncta coincidence was -0.004±0.002 (ONα), -
0.006±0.007 (ONT), and 0.001±0.005 puncta∙μm-1 (OFF𝛿 RGCs) (Figure 3.4B). 
Remaining GlyRα1 puncta found throughout the IPL but not on RGC dendrites 
could be expression on amacrine or bipolar cells. Or, some GlyRα1-positive puncta 
could also represent expression that was not fully eliminated by the Glra1-shRNA 
(C. Zhang et al., 2014). 
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Figure 3.4. GlyRα1 puncta expression is knocked down in rAAV-Glra1-shRNA 
infected ONα, ONT, and OFFδ RGCs. Ai-Aiii) Wholemount images of ONα, ONT, 
and OFFδ RGC dendrites (green) with GlyRα1 expression (red) (scale bar: 5μm). 
White arrows indicate representative co-localization of GlyRα1. Bi-Biii) Dendrites 
in ONα, ONT, and OFFδ RGCs with rAAV-Glra1-shRNA are similar between 
GlyRα1 puncta density co-localization in the original (ORI) orientation and 
coincidence co-localization in the rotated (RAN) orientation (Wilxocon Matched-
pairs T-test). The corrected puncta density for these cells: ONα is -0.004±0.002 
μm-1, ONT is -0.006±0.004 μm-1, and OFFδ is 0.001±0.005 μm-1. Ci-Ciii) The 
corrected puncta density for the Glra1KDrAAV ONα, ONT, and OFFδ RGCs is 
significantly lower than for WT RGCs (*p<0.05, **p<0.01, Two-Tailed Mann 
Whitney U-test). 
 
All Local Edge Detector, High Definition, and Ultra High Definition RGCs Express 
GlyRα1 and GlyRα3 
We examined the glycinergic isoform-specific expression and sIPSCs in 
fluorescently labeled WT RGCs in W3 reporter mice (Jacoby & Schwartz, 2017; T. 
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Kim, Soto, & Kerschensteiner, 2015). The GPF+ RGCs include three functional 
types, local edge detector (LED), high definition (HD), and ultra-high definition 
(UHD) RGCs. We compared the WT data across individual RGC types to 
determine if they differed in their measured GlyR kinetics. We found no difference 
in the glycinergic sIPSCs among these cells and we combined their results for the 
remainder of the analysis (Supplemental Figure 1). The mean τdecay of the 
glycinergic sIPSCs in all of the GFP+ RGCs was 7.5±0.2ms (Figure 3.5C), which 
is similar to previously published values for GlyRα3 (Gill et al., 2006; Majumdar et 
al., 2007) and significantly longer than the mean τdecay for α RGCs that express 
GlyRα1 (Figure 3.5B,C; p < 0.003, Two-tailed Mann Whitey U-test (C) 
Kolmogorov–Smirnov test p < 1.3e-121 (D). The frequency distribution of glycinergic 
sIPSC τdecay times in W3 RGC appeared to display a skewed distribution (Figure 
3.5D), indicating that not only the fast GlyRα3 mediates glycinergic synaptic 
events, but a GlyRα isoform with different kinetics may also play a role. 
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Figure 3.5. W3 RGCs appear to have GlyRα3-mediated sIPSCs. A) Raw traces 
of W3 RGC glycinergic sIPSCs in PTX/TPMPA, and PTX/TPMPA/STRYCH. B) 
Average traces of W3 (black) and ONα (grey) RGC glycinergic sIPSCs. C) The 
mean glycinergic sIPSC τdecay of W3 RGCs is significantly slower than the ONα 
RGCs (***p<0.003, Mann-Whitney U-test). D) Cumulative distributions of 
glycinergic sIPSC τdecay times (ms) for W3 and ONα RGCs. The cumulative 
distribution of glycinergic sIPSC τdecay in W3 RGCs is slower than the 
representative GlyRα1 expressing ONα RGC (Kolmogorov–Smirnov test). E) 
Frequency distribution of glycinergic sIPSC τdecay times for W3 RGCs (bin width is 
1 ms). 
 
WT W3 Glycinergic Synaptic Input is Mediated by GlyRα3, Glycinergic sIPSC 
frequency is reduced in Glra3-/- W3 RGCs 
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Our electrophysiological data is consistent with the expression of GlyRα3 in 
WT GPF+ W3 RGCs. To test this hypothesis, we recorded glycinergic sIPSCs in 
Glra3-/-/W3 retinas (Jacoby & Schwartz, 2017; I. J. Kim et al., 2010). The frequency 
of the glycinergic sIPSCs in Glra3-/-/W3 RGCs (regardless of RGC type) was 
9.6±1.2 events/sec, which is significantly lower (~ 35%) than W3 WT RGCs, which 
was 13.1±0.8 events/sec (Figure 3.6C; p < 0.01, One-way Analysis of Variance, 
Bonferroni Post-Hoc test). This result supports the idea that GlyRα3 is expressed 
by W3 RGCs, and the substantial frequency of the remaining glycinergic sIPSCs 
indicates that a second glycine receptor also mediates synaptic events. None of 
the sIPSC kinetics in the Glra3-/-/W3 differed significantly from WT. Further, the 
frequency distributions of the τdecay of the WT and Glra3-/- did not differ. Because 
neither decay frequency distribution had sIPSCs longer than 9ms, we 
hypothesized that GlyRα1 also contributed to glycinergic synaptic input. We tested 
this hypothesis and examined the rise time, amplitude, and decay characteristics 
of the remaining glycinergic sIPSCs. The remaining sIPSCs in the Glra3-/- were 
eliminated in the presence of strychnine (Figure 3.6A) In the Glra3-/-/W3 RGCs the 
average glycinergic sIPSC rise time remained 3.3±0.3, which was the same as WT 
RGCs, 3.1±0.3 (Figure 3.6D, p > 0.05, One-way Analysis of Variance, Bonferroni 
Post-Hoc test). The mean glycinergic sIPSC amplitude was 21.3±2.7 pA, which 
was also similar to WT at 23.3±1.4 pA (Figure 3.6E, p > 0.05, One-way Analysis 
of Variance, Bonferroni Post-Hoc test). The mean glycinergic sIPSC τdecay in Glra3-
/- W3 RGCs was 7.4±0.9 ms, and was similar to 7.5±0.9 ms in the WT (Figure 3.6F, 
p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test). The cumulative 
 
 
63 
 
glycinergic sIPSC τdecay distribution of the remaining glycinergic sIPSCs of the 
Glra3-/-/W3 RGCs was also similar to the WT W3 RGCs (Figure 3.6F; Kolmogorov–
Smirnov test, p > 0.4). However, since the Glra3-/- W3 glycinergic sIPSC τdecay 
distribution made no shift, it suggested the remaining glycinergic sIPSCs are 
mediated by GlyRα1, whose mean τdecay is ~3 msec (Figure 3.6F). If the distribution 
had shifted to the right it would indicate the remaining glycinergic sIPSCs were 
slow such as GlyRα2 or GlyRα4. We tested this idea and infected WT W3 retinas 
with rAAV-Glra1-shRNA.  
Glycinergic sIPSC frequency is reduced in rAAV-Glra1-shRNA W3 RGCs 
In rAAV-Glra1KD-shRNA infected WT GFP+ W3 RGCs, the glycinergic 
sIPSC frequency was significantly lower than both WT and Glra3-/- (2.5±0.5 
events/sec) (Figure 3.6C; p < 0.0001, One-way Analysis of Variance, Bonferroni 
Post-Hoc test) and the cumulative glycinergic sIPSC τdecay in rAAV-Glra1-shRNA 
infected W3 RGCs was significantly slower than WT, (Figure 3.6F; Kolmogorov–
Smirnov test, p < 4.95e-13). The mean τdecay was 10.1±1.0 ms, and was similar to 
WT (Figure 3.6F, p > 0.05). Together these results indicate that GlyRα1 mediated 
glycinergic synaptic inputs in W3 WT RGCs. In the absence of GlyRα1 expression, 
did not alter either the rise time or the amplitude of the remaining glycinergic 
sIPSCs compared to WT. Average rise time was 2.5±0.4 ms and amplitude was 
26.9±3.1 pA (Figure 3.6D, F; p > 0.05 for both, One-way Analysis of Variance, 
Bonferroni Post-Hoc test). To test the idea that both GlyRα3 and GlyRα1 are 
expressed and mediate sIPSCs, we infected Glra3-/-/W3 retinas with the rAAV-
Glra1-shRNA, and characterized the remaining glycinergic sIPSCs.  
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Glycinergic sIPSCs are eliminated in rAAV-Glra1-shRNA/Glra3 KO W3 RGCs 
Glycinergic sIPSCs were eliminated in Glra3-/-/Glra1KD W3 RGCs (0.4±0.1 
events/sec), which is statistically lower than WT and represents a 97% reduction 
of sIPSCs from WT (Figure 3.6C; p < 0.0001, One-way Analysis of Variance, 
Bonferroni Post-Hoc test). Together, these results indicate that W3 RGCs express 
both GlyRα3 and GlyRα1. The few glycinergic sIPSCs that remained in Glra3-/-
/Glra1KD W3 RGCs, could result from an incomplete knockdown of GlyRα1 
receptors, consistent with our previous findings (Zhang et al., 2014).  
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Figure 3.6. rAAV-mediated RNAi to Glra1 eliminates GlyRα1 sIPSC activity; 
Glra3-/- eliminates GlyRα3 sIPSC activity, in W3 RGCs. A) Raw traces of total, 
glycinergic (recorded in the presence of PTX/TPMPA), and strychnine sensitive 
(recorded in the presence of PTX/TPMPA/STRYCH) sIPSCs of Glra3-/-, Glra1KD, 
and Glra3-/-/Glra1KD W3 RGC. B) Average traces of WT (black), Glra3-/- (green), 
and Glra1KD (purple) W3 RGC glycinergic sIPSCs. C) Mean glycinergic sIPSC 
frequency (events/sec) for WT, Glra3-/-, Glra1KDrAAV, and Glra3-/-/Glra1KDrAAV 
W3 RGCs. The average glycinergic sIPSC frequencies of Glra3-/- and 
Glra1KDrAAV are significantly lower that WT, and the frequency in Glra3-/-
/Glra1KDrAAV is almost zero (One-Way Analysis of Variance with Bonferroni 
Post-Hoc test). D) Mean glycinergic sIPSC rise time (ms) for WT, Glra3-/-, 
Glra1KDrAAV W3 RGCs is similar (One-Way Analysis of Variance with Bonferroni 
Post-Hoc test). E) Average glycinergic sIPSC amplitude (pA) for WT, Glra3-/-, 
Glra1KDrAAV W3 RGCs is similar (One-Way Analysis of Variance with Bonferroni 
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Post-Hoc test). F) Cumulative distributions of glycinergic sIPSC τdecay times (ms) 
for WT, Glra1KD, and Glra3-/- W3 RGCs. The cumulative distribution of glycinergic 
sIPSC τdecay is significantly faster than WT in the Glra3-/- and significantly slower 
than WT in the Glra1KDrAAV (Kolmogorov–Smirnov test). G) Mean τdecay is 
similar among WT, Glra1KD, and Glra3-/- W3 RGCs (One-Way Analysis of 
Variance with Bonferroni Post-Hoc test). 
 
GlyRα1 but not GlyRα3 expression on WT W3 dendrites 
Immunohistochemical analysis were used to assess GlyRα3 and GlyRα1 
expression in WT W3 RGCs. The density of GlyRα3 puncta that co-localized with 
W3 dendrites did not differ from randomly associated puncta (Figure 3.7B,Di). 
GlyRα3 expression is dense throughout the IPL, although in a laminar pattern, and 
our assay, microscope, and deconvolution analysis are sensitive enough to 
adequately image these puncta. The W3 RGCs have dense bushy dendrites, 
which confound this analysis, especially if the overall expression of GlyRα3 on 
these cells is low, as indicated in the fact that Glra1KD reduces the glycinergic 
sIPSC frequency more than the Glra3-/-. Similarly, immunohistochemical analysis 
showed GlyRα1 expression co-localizes with W3 dendrites in both the original and 
random configurations (Figure 3.7B,Dii). From our immunohistochemical analysis 
of GlyRα1 expression on α RGCs, GlyRα1 puncta expression is dense throughout 
the IPL and we successfully measured corrected puncta density. However, the W3 
RGC bushy dense dendrites, and the possibility of low GlyRα1 expression on these 
cells, may prevent our immunohistochemical analysis from being sensitive enough 
to detect GlyRα1 puncta expression on W3 RGCs.  
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Figure 3.7. GlyRα1 and GlyRα3 puncta are not detectable on W3 RGCs Ai-Aiii) 
Wholemount image of W3 RGC (UHD RGC) (scale bar: 40μm). B) Wholemount 
image of W3 RGC dendrites stained for GlyRα1 expression (red). White arrows 
indicate representative co-localization of GlyRα1. C) Wholemount image of 
Dendrites of W3 RGC dendrites stained for GlyRα3 expression (red) (scale bar: 
5μm). Di) W3 RGCs have similar GlyRα3 puncta density co-localization (μm-1) to 
coincidence co-localization in the flipped (RAN) orientation (Wilxocon Matched-
pairs U-test). The corrected puncta density of GlyRα3 for W3 RGCs is -
0.004±0.012 μm-1. Dii) W3 RGCs have similar GlyRα1 puncta density co-
localization (μm-1) with coincidence co-localization in the flipped (RAN) 
orientation (Wilxocon Matched-pairs U-test). The corrected puncta density of 
GlyRα3 for W3 RGCs is 0.008±0.021 μm-1. 
 
 
Asymmetric OFFT (F-mini) WT RGCs Glycinergic Synaptic Input is Mediated by 
GlyRα2 and GlyRα3 
We examined the glycinergic isoform-specific expression and synaptic 
currents in F-mini RGCs that are GFP+ in PVCre/Thy1STP reporter mice. We 
identified F-mini RGCs among other GFP+ RGCs because of their small somas 
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(~10μm dia.), asymmetric dendritic arbor that ramified in the OFF sublamina of the 
IPL and their OFFTransient visually-evoked responses. These cells also have been 
referred to as PV7 RGCs (Farrow et al., 2013; Rousso et al., 2016). In the presence 
of PTX [20μM] and TPMPA [50μm], the glycinergic sIPSCs in WT F-mini RGCs 
had an average τdecay of 6.5±0.5 ms, similar to the average in W3 WT RGCs and 
to published τdecay values for GlyRα3 mediated sIPSCs (Figure 3.8A-C) (Gill et al., 
2006; Majumdar et al., 2007). The frequency distribution of their τdecay appears to 
be skewed and includes sIPSCs with decays slower than GlyRα1 or > 3 msec. We 
considered that this could indicate expression of either GlyRα2 or GlyRα4 (Figure 
3.8D). 
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Figure 3.8. F-mini RGCs appear to have GlyRα3-mediated sIPSCs. A) Raw 
traces of F-mini RGC glycinergic sIPSCs and strychnine sensitive sIPSCs. The “ 
* “ indicates a glycinergic sIPSC. B) Average traces of F-mini (black) and ONα 
(grey) RGC glycinergic sIPSCs. C) Cumulative distributions of glycinergic sIPSC 
τdecay times (ms) for F-mini and ONα RGCs. The cumulative distribution of 
glycinergic sIPSC τdecay in F-mini RGCs is slower than the representative GlyRα1 
expressing ONα RGC (Kolmogorov–Smirnov test). D) Frequency distribution of 
glycinergic sIPSC τdecay times for F-mini RGCs (bin width is 1 ms). E) The mean 
glycinergic sIPSC τdecay of F-mini RGCs is significantly slower than the ONα 
RGCs (Mann-Whitney U-test). 
 
Glycinergic sIPSC frequency is reduced in Glra3-/- F-mini RGCs 
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To test the hypothesis that WT F-mini RGCs express GlyRα3, we recorded 
glycinergic sIPSCs in Glra3-/- F-mini RGCs and found that their frequency was 
significantly lower compared to WT (4.4±1.1 vs. 14.1±1.3 events/sec; respectively; 
Figure 3.9C; p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test). 
The average τdecay of the remaining glycinergic sIPSCs (10.2±0.4 ms) was 
significantly slower than WT (Figure 3.9F, p < 0.04, One-way Analysis of Variance, 
Bonferroni Post-Hoc test) and the cumulative sIPSC τdecay curve was shifted to 
larger values (Figure 3.9G, Kolmogorov–Smirnov test, p < 2.3e-74. We 
characterized the remaining glycinergic sIPSCs and found their mean amplitude 
was significantly lower than WT (21.8±2.8 vs 31.8±2.6 pA; respectively; Figure 
3.9E, p < 0.002, One-way Analysis of Variance, Bonferroni Post-Hoc test). Their 
rise time was similar to WT (2.5±0.4 vs 1.8±0.1 ms; respectively; Figure 3.9D, p > 
0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test). Together the data 
suggest that WT F-mini’s express GlyRα3 and one of the glycine α subunits with 
slow decay kinetics, GlyRα2 or GlyRα4.  
Glycinergic sIPSC frequency is reduced in Glra2-/- F-mini RGCs 
To test the hypothesis that GlyRα2 receptors mediate synaptic currents in 
F-mini OFFTransient RGCs, we recorded sIPSCs in Glra2-/- F-mini RGCs. The 
frequency of glycinergic sIPSCs was significantly less in Glra2-/- F-mini RGCs 
(8.5±1.3 events/sec) compared to WT (14.1±1.3 events/sec); Figure 3.9C; p < 
0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test). The average 
Glra2-/- F-mini glycinergic sIPSC τdecay (7.8±0.4 ms) was similar to WT (Figure 
3.9G,p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test) and 
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surprisingly, their cumulative sIPSC τdecay curve shifted significantly to slower 
values compared to WT (Figure 3.9F, Kolmogorov–Smirnov test, p < 2.46e-10). 
This was surprising since GlyRα3-mediated sIPSCs are slower than WT and we 
expected this curve to shift to slower values. The average rise time of the 
glycinergic sIPSCs in the Glra2-/- F-mini RGCs was similar to WT and to Glra3-/- 
(2.0±0.1 ms; Figure 3.9D, p > 0.05, One-way Analysis of Variance, Bonferroni 
Post-Hoc test). The mean amplitude of Glra2-/- F-mini RGCs glycinergic sIPSCs 
also was similar to WT (22.4±3.0 pA; Figure 3.9E, p > 0.05, One-way Analysis of 
Variance, Bonferroni Post-Hoc test). These results suggest that both GlyRα2 and 
GlyRα3 mediate synaptic inputs in F-mini RGCs.  
Glycinergic sIPSC frequency is eliminated in Glra2-/-/Glra3-/- F-mini RGCs 
When we recorded glycinergic synaptic inputs in Glra2-/-/Glra3-/- double KO 
F-mini RGCs there were almost no sIPSCs (0.6±0.3 events/sec a decrease of ~ 
96%), which was significantly lower than WT and Glra2-/- F-mini RGCs (Figure 
3.9C; p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test). These 
results combined with the puncta expression results demonstrate that F-mini 
RGCs express both GlyRα2 and GlyRα3. 
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Figure 3.9. F-mini RGC glycinergic sIPSC activity is eliminated in Glra2-/-/Glra3-/-. 
A) Raw traces of total and glycinergic sIPSCs of Glra3-/-, Glra2-/-, and Glra2-/-
/Glra3-/-F-mini RGCs. B) Average traces of WT (black), Glra3-/- (green), and 
Glra2-/- (blue), F-mini RGC glycinergic sIPSCs. C) Mean glycinergic sIPSC 
frequency (events/sec) for WT, Glra3-/-, Glra2-/-, and Glra2-/-/Glra3-/- F-mini RGCs. 
The average glycinergic sIPSC frequencies of Glra3-/- and Glra2-/- are 
significantly lower that WT, and the frequency in Glra2-/-/Glra3-/- is almost zero 
(One-Way Analysis of Variance with Bonferroni Post-Hoc test). D) Mean 
glycinergic sIPSC rise times (ms) for WT, Glra3-/-, Glra2-/-, and Glra2-/-/Glra3-/- F-
mini RGCs are similar (One-Way Analysis of Variance with Bonferroni Post-Hoc 
test). E) The Average glycinergic sIPSC amplitude (pA) for Glra2-/- is similar to 
both WT, and Glra3-/- (One-Way Analysis of Variance with Bonferroni Post-Hoc 
test). The average glycinergic sIPSC amplitude for Glra3-/- is significantly lower 
than WT (One-Way Analysis of Variance with Bonferroni Post-Hoc test). F) The 
mean glycinergic sIPSC τdecay time of the Glra3-/- F-mini RGC is significantly 
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slower than WT, however no different from the Glra2-/- F-mini RGC. The Glra2-/- 
F-mini RGC mean glycinergic sIPSCs τdecay time is similar to WT. G) Cumulative 
distribution of glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-, Glra3-/- F-mini 
RGCs. The cumulative distribution of glycinergic sIPSC τdecay is significantly 
slower in the Glra2-/-, Glra3-/-, and Glra2-/-/ Glra3-/- (Kolmogorov–Smirnov test).  
 
GlyRα2 and GlyRα3 expression on WT F-mini dendrites 
To validate our electrophysiological recordings, we assessed the 
immunoreactivity of F-mini WT RGCs dendrites for GlyRα3 and GlyRα2 positive 
puncta. We measured the density of each of these puncta and compared them to 
an estimate of random puncta coincidence. Both GlyRα3 and GlyRα2 puncta 
density was significantly higher than random coincidence (GlyRα3 0.16±0.01 
puncta∙μm-1; GlyRα2 0.28±0.03 puncta∙μm-1; respectively (Figure 3.10Di, Dii, p < 
0.0003; 0.0001 (paired one-tailed T-test). Their average corrected puncta density 
was (GlyRα3 0.05±0.01 puncta∙μm-1; GlyRα2 0.22±0.02 puncta∙μm-1. These 
results support our hypothesis that synaptic input to WT F-mini RGCs is mediated 
by both GlyRα3 and GlyRα2. 
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Figure 3.10. F-mini RGCs Express GlyRα2 and GlyRα3. (Images and GlyRα3 
puncta count data sourced from (C. Zhang, 2015). A) Wholemount image of F-
mini RGC filled with neurobiotin (scale bar: 40μm). B) Wholemount image of F-
mini RGC dendrites stained for GlyRα3 expression (red) (scale bar: 5μm). White 
arrows indicate representative co-localization of GlyRα3. C) Wholemount image 
of F-mini RGC dendrites stained for GlyRα2 expression (red) (scale bar: 5μm). 
White arrows indicate representative co-localization of GlyRα2. Di) Dendrites in 
WT F-mini RGCs have significantly more GlyRα3 puncta density co-localization 
(μm-1) than coincidence co-localization in the flipped (RAN) orientation (Wilxocon 
matched-pairs U-test). The corrected puncta density for GlyRα3 puncta on F-mini 
RGCs is 0.05±0.01 μm-1. Dii) Dendrites in WT F-mini RGCs have significantly 
more GlyRα2 puncta density co-localization (μm-1) than coincidence co-
localization in the flipped (RAN) orientation (Wilxocon matched-pairs U-test). The 
corrected puncta density for GlyRα2 puncta on F-mini RGCs is 0.22±0.02 μm-1. 
 
Glycinergic Synaptic Input to J-RGCs is Mediated by GlyRα2 
We examined the glycinergic isoform-specific expression and sIPSCs in 
asymmetric, intrinsically orientation selective J-RGCs. These were included in 
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color encoding YFP+ J-RGCs in tamoxifen injected JAM-BCreER reporter mice 
(Figure 3.11) (I. J. Kim, Zhang, Yamagata, Meister, & Sanes, 2008; Liu & Sanes, 
2017; Sanes & Masland, 2015). In the presence of GABAAR and GABACR 
antagonists, the average τdecay of glycinergic sIPSCs in WT J-RGCs was 23.3±0.5 
ms (Figure 3.11B-D). The in presence of strychnine, all glycinergic sIPSCs were 
eliminated Figure 3.11A). The slow τdecay indicates that synaptic glycinergic 
currents in J-RGCs are mediated by either GlyRα2 or GlyRα4 whose mean sIPSC 
τdecays are slower than τdecays mediated by either GlyRα1 or GlyRα3 (Figure 
3.11B,C). Furthermore, the frequency distribution of J-RGC glycinergic sIPSC 
τdecay is skewed and may represent the expression of more than one slow GlyR α 
subunit (Figure 3.11D).  
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Figure 3.11. J-RGCs appear to have GlyRα2 or GlyRα4-mediated sIPSCs. A) 
Raw traces of J-RGC glycinergic sIPSCs. The “ * “ indicates a glycinergic sIPSC. 
Glycinergic sIPSCs are isolated in the presence of PTX/TPMPA and eliminated 
in the presence of PTX/TPMPA/STRYCH. B) Average traces of J-RGC (black), 
W3 (green), and ONα RGC (grey) glycinergic sIPSCs. C) The mean τdecay of J-
RGC glycinergic sIPSCs is significantly more than the mean τdecay of both WT 
and ONα RGCs (One-Way Analysis of Variance with Bonferroni Post-Hoc test). 
D) Cumulative distributions of glycinergic sIPSC τdecay times (ms) for J-RGCs 
(black), W3 RGCs (green) and ONα RGCs (grey). The cumulative distribution of 
glycinergic sIPSC τdecay in J-RGCs is slower than both the representative GlyRα1 
expressing ONα RGCs and the representative GlyRα3 expressing W3 RGCs 
(Kolmogorov–Smirnov test). E) Frequency distribution of glycinergic sIPSC τdecay 
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times for J-RGCs is skewed (bin width is 3 ms). F) Wholemount image of J-RGC 
filled with Lucifer Yellow (scale bar: 50μm). 
 
J-RGCs express GlyRα2 
We tested the hypothesis that J-RGCs express GlyRα2 and recorded 
glycinergic sIPSCs in Glra2-/-/J-RGCs and found the average frequency was 
significantly less than WT (1.2±0.2 vs. 2.6±0.4 events/sec, respectively; Figure 
3.12C; p < 0.001, One-way Analysis of Variance, Bonferroni Post-Hoc test). The 
average Glra2-/-/J-RGC glycinergic sIPSC τdecay was significantly faster than WT 
(16.3±0.6 ms; Figure 3.12D; p < 0.01, One-way Analysis of Variance, Bonferroni 
Post-Hoc test). Similarly, the cumulative distribution curve of glycinergic sIPSC 
τdecay in Glra2-/-/J-RGCs was shifted to faster decays compared to WT (Figure 
3.12E; p < 8.14e-16, Kolmogorov–Smirnov test). The rise time of Glra2-/-- J-RGCs 
was significantly slower than WT J-RGCs (4.9±0.4 vs 3.5±0.2, respectively; (Figure 
3.12F, p < 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test) although 
their amplitude was similar to WT (21.3±2.2 pA; Figure 3.12G, p > 0.05, One-way 
Analysis of Variance, Bonferroni Post-Hoc test). These data suggest that the 
remaining sIPSCs in Glra2-/- J-RGCs are mediated by GlyRα4 and we tested this 
idea, by recording sIPSCs in Glra2-/-/Glra4-/- J-RGCs. These remaining glycinergic 
sIPSCs were eliminated in the presence of strychnine (Figure 3.12A).  
Glra2-/-/Glra4-/- J-RGCs Have Similar Synaptic Input to Glra2-/- 
In Glra2-/-/Glra4-/- J-RGCs, the frequency of glycinergic sIPSC was 
significantly lower compared to WT (0.7±0.1, a 72% reduction; Figure 3.12C; p < 
0.01, One-way Analysis of Variance, Bonferroni Post-Hoc test). Although the 
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frequency of glycinergic sIPSCs in Glra2-/-/Glra4-/- compared to Glra2-/- J-RGCs it 
did not differ significantly (Figure 3.12C, p > 0.05, One-Way Analysis of Variance 
with Bonferroni Post-Hoc test). The characteristics of the remaining glycinergic 
sIPSCs were similar to WT, the average rise time of Glra2-/-/Glra4-/- J-RGCs 
glycinergic sIPSCs was still slow, and the amplitude also did not vary (19.0±1.0; 
Figure 3.12F,G, p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc 
test). While the average τdecay was similar to WT (Figure 3.12D; p < 0.05, One-way 
Analysis of Variance, Bonferroni Post-Hoc test); the cumulative τdecay was 
significantly slower compared to WT (Figure 3.12E, Kolmogorov–Smirnov test, p 
< 5e-10). It is clear from these results that WT J-RGCs synaptic inputs are mediated 
by GlyRα2. What remains to be tested is whether GlyRα4 also mediates J-RGC 
glycinergic sIPSCs and if the puncta of GlyRα2 and GlyRα4 are colocalized on the 
J-RGC dendrites. 
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Figure 3.12. Glra2-/-/Glra4-/- eliminates glycinergic sIPSC activity in J-RGCs. A) 
Raw traces of total and glycinergic sIPSCs of Glra2-/- and Glra2-/-/Glra4-/- J-RGCs. 
GlyR sIPSCs are isolated in the presence of PTX/TPMPA and the all sIPSCs are 
eliminated in the presence of PTX/TPMPA/STRYCH. B) Average traces of WT 
(black), Glra2-/- (blue), and Glra2-/-/Glra4-/- (purple) J-RGC glycinergic sIPSCs. C) 
The Mean glycinergic sIPSC frequency (events/sec) for WT, Glra2-/-, Glra2-/-
/Glra4-/- J-RGCs. The average glycinergic sIPSC frequencies of Glra2-/- and 
Glra2-/-/Glra4-/- are significantly lower that WT, however the glycinergic sIPSC 
frequency was similar between the Glra2-/- and Glra2-/-/Glra4-/- (One-Way 
Analysis of Variance with Bonferroni Post-Hoc test). D) The mean glycinergic 
sIPSC τdecay time of the Glra3-/- F-mini RGC is significantly slower than WT, 
however no different from the Glra2-/- F-mini RGC. The Glra2-/- F-mini RGC mean 
glycinergic sIPSCs τdecay time is similar to WT. E) Cumulative distribution of 
glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-, and Glra2-/-/Glra4-/- J-RGCs. 
The cumulative distribution of glycinergic sIPSC τdecay is significantly faster the 
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Glra2-/-, then Glra2-/-/ Glra3-/- (Kolmogorov–Smirnov test). F) The mean rise times 
(ms) of J-RGC glycinergic sIPSCs for WT, Glra2-/-, and Glra2-/-/Glra4-/-. The mean 
Glra2-/- J-RGC glycinergic sIPSC rise time was significantly faster than WT (one-
way analysis of variance with Bonferroni post-hoc test). G) The Average 
glycinergic sIPSC amplitude (pA) for WT, Glra2-/-, and Glra2-/-/Glra4-/-was similar 
among these three genotypes (One-Way Analysis of Variance with Bonferroni 
Post-Hoc test).  
 
WT ON SAC Glycinergic Synaptic Input is Mediated by GlyRα2 
 We targeted ON SACs using tdTomato+ ChAT-cre/ai9 mouse (Rossi et al., 
2011). In the presence of PTX [20μM] and TPMPA [50μm], ON SAC glycinergic 
sIPSCs were slow and had an average τdecay of 28.4±0.7 ms, suggesting GlyRα2 
and/or GlyRα4 mediate these synaptic events, and these events were eliminated 
in the presence of strychnine (Figure 3.13A-D) It was previously reported that the 
ON SACs express slow glycinergic sIPSCs (Majumdar et al., 2009). The frequency 
distribution of the ON SAC glycinergic sIPSC τdecay shows a skewed distribution, 
indicative of the expression of more than one kinetically disparate GlyR (Figure 
3.13E).  
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Figure 3.13. ON SAC glycinergic sIPSCs are slow and mediated by either 
GlyRα2 or GlyRα4. A) Raw trace of glycinergic sIPSC of ON SACs. GlyR sIPSCs 
are isolated in the presence of PTX/TPMPA and all sIPSCs are eliminated in the 
presence of PTX/TPMPA/STRYCH. B) Average trace of ON SAC glycinergic 
sIPSCs with similar GlyRα2 mediated J-RGC trace for reference. C) Cumulative 
distribution of glycinergic sIPSC τdecay times (ms) for ON SAC and J-RGCs. 
There is a significant difference between the different genotypes (Kolmogorov–
Smirnov test). D) Mean glycinergic sIPSC τdecay for ON SACs and J-RGCs were 
similar (p > 0.05, Mann-Whitney t-test). E) Frequency distribution of glycinergic 
sIPSC τdecay of ON SACs. 
 
Glycinergic sIPSC frequency is reduced in Glra2-/-ON SACs 
We characterized the remaining glycinergic sIPSCs in Glra2-/- ON SACs 
and found that the average frequency was significantly lower compared to WT 
(0.4±0.1 vs. 1.13±0.2 events/sec, respectively; Figure 3.14C, p < 0.002, One-way 
Analysis of Variance, Bonferroni Post-Hoc test). The remaining glycinergic sIPSCs 
were eliminated in the presence of strychnine (Figure 3.14A). As noted in the J-
RGCs, comparisons of the average of glycinergic sIPSC τdecays between Glra2-/- 
and WT ON SAC were similar (25.72±0.92 ms vs.25.5±2.4 ms, respectively), but 
the cumulative distribution curves of Glra2-/- and WT ON SACs differed significantly 
and Glra2-/- ON SAC decays were faster (Figure 3.14F; Kolmogorov–Smirnov test, 
p < 6.5e-5). Neither glycinergic sIPSC rise time (3.6±0.5 ms) nor amplitude 
(18.9±1.5 vs 27.5±2.7 pA; Figure 3.14D,E, p > 0.05, One-way Analysis of Variance, 
Bonferroni Post-Hoc test) of Glra2-/- ON SACs differed from WT. The significant 
decrease in glycinergic sIPSC frequency suggests that WT ON SACs express 
GlyRα2. The characteristics of the remaining Glra2-/- ON SAC glycinergic sIPSCs 
indicates that their glycinergic synaptic inputs also might be mediated by GlyRα4. 
Glycinergic sIPSC frequency is Not Reduced in Glra4-/-ON SACs 
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 We also recorded glycinergic sIPSCs in Glra4-/- ON SAC and found that 
while the frequency was about half of WT, it was not statistically different (0.6±0.2 
events/sec; Figure 3.14D; p > 0.05, One-way Analysis of Variance, Bonferroni 
Post-Hoc test). The characteristics of the glycinergic sIPSCs in the Glra4-/- ON 
SACs were all similar to WT and were eliminated in the presence of strychnine 
(Figure 3.14A-F, p > 0.05 for all, One-way Analysis of Variance, Bonferroni Post-
Hoc test). 
Glycinergic sIPSCs are not reduced further in Glra2-/-/Glra4-/-ON SACs 
We recorded glycinergic sIPSCs in the Glra2-/-/Glra4-/- ON SACs and while 
their mean frequency was lower (0.3±0.1 events/sec) it did not differ significantly 
from Glra2-/- or Glra4-/- single KO cells (Figure 3.14C; p < 0.0002, One-way 
Analysis of Variance, Bonferroni Post-Hoc test). These remaining sIPSCs were 
eliminated by strychnine (Figure 3.14A). The mean amplitude of the glycinergic 
sIPSCs in Glra2-/-/Glra4-/- ON SACs was significantly lower than WT (16.8±1.1 pA; 
Figure 3.14E, p < 0.02, One-way Analysis of Variance, Bonferroni Post-Hoc test), 
which indicates a reduction in presynaptic glycine release and potential upstream 
modifications. The rise time and the τdecay of the remaining glycinergic sIPSCs were 
similar to WT (Figure 3.14D,F, p > 0.5 for both , One-way Analysis of Variance, 
Bonferroni Post-Hoc test). The cumulative distribution of ON SAC glycinergic 
sIPSC τdecay also was similar to Glra2-/- ON SACs (Figure 3. 14F, Kolmogorov–
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Smirnov test, p > 0.1). From these data, we conclude the ON SACs express 
GlyRα2.  
 
Figure 3.14. ON SAC glycinergic sIPSCs are slow and mediated by GlyRα2. A) 
Raw traces of glycinergic sIPSCs of ON SACs in Glra2-/-, Glra4-/- and Glra2-/-
/Glra4-/-. GlyR sIPSCs were isolated in the presence of PTX/TPMPA and all 
sIPSCs were eliminated in the presence of PTX/TPMPA/STRYCH. B) Average 
traces of ON SAC glycinergic sIPSCs in WT, Glra2-/-, Glra4-/- and Glra2-/-/Glra4-/-. 
C) Mean glycinergic sIPSC frequency (events/sec) for WT, Glra2-/-, Glra4-/-, and 
Glra2-/-/Glra4-/- ON SACs. The average glycinergic sIPSC frequencies 
(events/sec) of Glra2-/- and Glra2-/-/Glra4-/- are significantly less than WT, the 
latter being almost zero (one-way analysis of variance with Bonferroni post-hoc 
test). D) Mean glycinergic sIPSC rise time (ms) for WT, Glra2-/-, Glra4-/-, and 
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Glra2-/-/Glra4-/- ON SACs. All rise times observed were similar (p > 0.05, One-
Way Analysis of Variance with Bonferroni Post-Hoc test). E) Mean amplitude 
observed for the ON SACs in WT, Glra2-/-, Glra4-/- and Glra2-/-/Glra4-/-. Only the 
mean amplitude (pA) in the Glra2-/-/Glra4-/- was significantly lower than WT (p < 
0.02, One-Way Analysis of Variance with Bonferroni Post-Hoc test). F) 
Cumulative distribution of glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-, 
Glra4-/-, and Glra2-/-/Glra4-/- ON SACs. The Glra2-/- and the Glra2-/-/Glra4-/- curves 
were both significantly different from WT, but were similar to each other 
(Kolmogorov–Smirnov test). G) The mean glycinergic sIPSC τdecay was similar 
among the WT, Glra2-/-, Glra4-/-, and Glra2-/-/Glra4-/- ON SACs (p > 0.05, One-
Way Analysis of Variance with Bonferroni Post-Hoc test). 
 
GlyRα2 and GlyRα4 Expression on WT ON SACs processes  
Previously published data reported that ON SACs express GlyRα4 (Heinze 
et al., 2007; Majumdar et al., 2009; Weiss et al., 2008). Our electrophysiology data 
suggest the ON SACs express GlyRα2, GlyRα4, or both. We examined puncta 
expression on ON SACs express and found that the average GlyRα2-positive 
puncta density coincident with ON SAC dendrites was 0.15±0.02 μm-1 and the 
average random GlyRα2-positive puncta density was significantly less (0.08±0.01 
μm-1; Figure 3.15C, Dii; p < 0.005, one tailed paired T-test). The average corrected 
GlyRα2-positive puncta density was 0.07±0.01 μm-1 (Figure 3.15Dii). We also 
found the average GlyRα4-positive puncta density coincident with ON SAC 
dendrites was similar to that of GlyRα2 and was 0.17±0.02 μm-1. The average 
random GlyRα4-positive puncta density was (0.12±0.03 μm-1) and significantly 
lower than the original puncta density (Figure 3.15B, Di; p < 0.05, one-tailed paired 
T-test). The average corrected GlyRα4-positive puncta density was 0.05±0.01 
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(Figure 3.15Di). While the GlyRα2 expression supports our electrophysiological 
data, more work is needed to reconcile the GlyRα4 expression on these ACs.  
 
Figure 3.15. ON SACs Express GlyRα2 and GlyRα4 puncta. (Images sourced 
from (C. Zhang, 2015). A) Wholemount image of ON SAC filled with neurobiotin 
(scale bar: 40μm). B) Wholemount image of ON SAC dendrites stained for 
GlyRα4 expression (red) (scale bar: 5μm). White arrows indicate representative 
co-localization of GlyRα4. C) Wholemount image of ON SAC dendrites stained 
for GlyRα2 expression (red) (scale bar: 5μm). White arrows indicate 
representative co-localization of GlyRα2. Di) Dendrites in ON SACs have 
significantly more GlyRα4 puncta density co-localization than coincidence co-
localization in the flipped (RAN) orientation (Wilxocon matched-pairs U-test). The 
corrected puncta density for GlyRα4 puncta on SACs is 0.05±0.01 μm-1. Dii) 
Dendrites in SACs have significantly more GlyRα2 puncta density co-localization 
(μm-1) than coincidence co-localization in the flipped (RAN) orientation (Wilxocon 
matched-pairs U-test). The corrected puncta density for GlyRα2 puncta on SACs 
is 0.07±0.01 μm-1. 
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DISCUSSION 
 
 The four heteromeric GlyRs found in the retina have different decay kinetics, 
and their expression is differential. One can speculate on GlyR inhibitory function, 
but given the diversity of GlyR expression on the RGCs we assessed, their function 
should be measured based on individual RGC specific GlyR expression and the 
specific RGC type and visual response properties. Until recently, GlyR expression 
on specific RGCs was only predicted and has been verified for one RGC, the OFFα 
RGC (C. Zhang et al., 2014). Using a similar approach with rAAV-Glra1-shRNA to 
knock down the expression of GlyRα1 and a variety of GlyR KO models, we 
resolved the GlyR expression for a nine different RGCs and one AC that 
encompass roughly 50% of all RGCs found in the mouse retina (Sanes & Masland, 
2015), as well as the ON SAC. Our survey of GlyR expression in RGCs presents 
an opportunity to elucidate the function of GlyRs in specific inhibitory circuits, 
involving specific RGCs. 
ONα, ONT, OFFα, and OFFδ RGC Glycinergic Synaptic Inputs 
Our lab previously determined OFFα RGCs express GlyRα1, the GlyR with 
the fastest kinetics (C. Zhang et al., 2014). Using the same approach, we 
ascertained that all RGCs with the largest soma diameters (Onα, ONT, OFFα, and 
OFFδ) express only GlyRα1. The τdecay of GlyRα1 mediated sIPSCs elsewhere in 
the CNS is about 2-4 ms, thus our identification of GlyRα1 expression on the RGC 
types with the largest somas is comparable to the kinetics of other confirmed 
GlyRα1 mediated currents (Figure 3.1) (Legendre, 1999; Majumdar et al., 2007). 
Furthermore, we assessed the GlyRα1-postive puncta on the α RGC dendrites, 
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and positively identified its expression in WT α RGCs and its absence in rAAV-
Glra1-shRNA infected α RGCs. Zhang et al. previously determined that GlyRα1 
input on OFFα RGCs helps modulate the spontaneous excitatory activity to 
improve the signal to noise ratio, and slightly hyperpolarizes the cell reducing the 
spiking probability. Furthermore, GlyRα1 input in OFFα RGCs helps diminish the 
rebound excitation caused by the transient suppression of spiking from ON cone 
bipolar cells during an OFFset stimulus. Finally, OFFα RGCs receive crossover 
inhibition mediated by glycinergic input from the AII amacrine cell during the ONset 
of light. It is very likely the role of GlyRα1 is similar in the other RGCs with the 
largest somas where it modulates spontaneous activity, and the fidelity of spiking 
responses is enhanced. However, further studies are necessary to elucidate the 
function of GlyRα1 on the ONα, ONT, and OFFδ RGCs since their dendrites ramify 
in different locations of the IPL, they likely receive input from glycinergic amacrine 
cells other than the AII, and they are part of different parallel pathways. 
W3 RGC Glycinergic Synaptic Input 
Using our electrophysiological analysis we established that all fluorescent 
RGCs found in the W3 reporter line express both GlyRα1 and GlyRα3; of the four 
GlyRs these two have the fastest kinetics (Gill et al., 2006; Majumdar et al., 2007; 
Majumdar et al., 2009). The established immunohistochemical approach we used 
to identify GlyR puncta expression was not sensitive enough to positively identify 
GlyRα1 and GlyRα3 on W3 RGCs. It is possible the GlyR expression on these 
cells is lower than GlyR expression on other cells where we successfully identified 
GlyR puncta expression. Additionally, each W3 RGC type has bushy and dense 
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dendrites, which complicate our analysis where randomly associated puncta 
expression could easily merge with a dendrite. Nevertheless, the drastic reduction 
in glycinergic sIPSC activity in the Glra3-/- + rAAV-Glra1-shRNA indicate GlyRα1 
and GlyRα3 are expressed on W3 RGCs.  
All W3 RGCs (LED, HD, and UHD RGCs) have small somas, bushy 
dendritic fields, and stratify in the middle of the IPL. Additionally, these cells 
respond to both the ONset and OFFset of a receptive field center-sized spot 
stimulus (Jacoby & Schwartz, 2017). However, each W3 RGC type differs in its 
visual response kinetics, either sustained, transient, or a combination for the ON 
and OFF responses. Since these RGCs express two GlyRs, it is possible each one 
subserves a separate function, or a single function results from the complementary 
interaction of both GlyRs. Since the W3 RGCs receive input from both the ON and 
OFF pathway, it is likely that more sophisticated inhibitory synapses are required 
to help modulate both of these inputs. It is feasible these two GlyRs have a role in 
maintaining the spontaneous activity and improving the fidelity of the signal. 
Moreover, though we concluded all W3 RGCs express both GlyRα1 and GlyRα3, 
further study is needed evaluate the specific inhibitory function of these GlyRs on 
the individual LED, UHD, and HD RGCs. 
F-mini RGC Glycinergic Synaptic Input 
The F-mini OFFT RGCs express both GlyRα2 and GlyRα3; a slow GlyR and 
a fast GlyR, respectively (Haverkamp et al., 2004; Heinze et al., 2007; Majumdar 
et al., 2009; Weiss et al., 2008; C. Zhang et al., 2015). We demonstrated the 
puncta expression of both GlyRα2 and GlyRα3 on the dendrites of the F-mini 
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RGCs. However, in the Glra3-/-, F-mini GlyR activity (which is presumed to be 
mediated by GlyRα2) is much faster than isolated GlyRα2 activity observed in 
other cells such as the ON SACs (Haverkamp et al., 2004; Weiss et al., 2008; C. 
Zhang & McCall, 2012; C. Zhang et al., 2015). Perhaps the GlyRα2 expressed on 
F-mini RGCs is a second splice variant with much faster kinetics than the 
previously reported ~20-40 ms (Majumdar et al., 2009; Miller, Harvey, & Smart, 
2004). Surprisingly, the F-mini glycinergic sIPSCs recorded in the Glra2-/-, 
originating from GlyRα3 receptors, have a similar average τdecay to WT. 
Furthermore, the cumulative distribution curve of the Glra2-/- glycinergic sIPSC 
τdecay is shifted to the right from WT as opposed to the left. Thus, in the single KOs 
of F-mini RGCs, the independent GlyRα2 and independent GlyRα3 decay kinetics 
are slower than the complementary interaction of the two GlyRs in the WT F-mini 
RGCs. Though this result is confusing, it is possible it is derived from a change 
auxiliary protein modification of the remaining glycine receptor in the single KO, or 
from an alteration from connatural receptor expression density on the F-mini RGC. 
Further investigation using an rAAV-Glra2KD-shRNA or rAAV-Glra3KD-shRNA, 
which only infects RGCs, may better demonstrate the function of GlyRs on F-mini 
RGCs and also unveil how a global GlyR KO may disrupt spontaneous glycine 
release onto the RGCs. 
J-RGC Glycinergic Synaptic Input 
 Our evidence indicates J-RGCs express GlyRα2 since the glycinergic 
sIPSC activity in Glra2-/- J-RGCs decreased significantly and the mean τdecay was 
faster than WT. Glycinergic sIPSCs remained in the Glra2-/- so we measured 
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synaptic glycinergic currents in the Glra2-/-/Glra4-/- but found little difference in 
these measurements from the Glra2-/-. Our overall conclusion is J-RGCs express 
GlyRα2. Despite the low glycinergic sIPSC frequency in the Glra2-/- and Glra2-/-
/Glra4-/-, it is apparent that kinetically slow glycinergic sIPSCs remain. It is also 
curious that the remaining J-RGC glycinergic sIPSCs in the Glra2-/-/Glra4-/- have a 
mean τdecay similar to WT. Further investigation is needed to identify the remaining 
GlyR expression on J-RGCs, including an immunohistochemical analysis of GlyR 
puncta expression. 
ON SAC Glycinergic Synaptic Input  
We demonstrated using immunohistochemistry that ON SACs express both 
GlyRα2 and GlyRα4; the two kinetically slow GlyRs. Curiously, our glycinergic 
sIPSC analysis determined the ON SACs only express GlyRα2. All authors 
investigating the glycinergic inhibition of ON SACs established these cells express 
GlyRα4 (Majumdar et al., 2009; Weiss et al., 2008). Furthermore, 
immunohistochemical experiments indicate that there is dense GlyRα4 expression 
in the ON ChAT band, which increases the likelihood of GlyRα4 expression on any 
dendrites of cells that ramify in this location, such as the ON SACs (Haverkamp, 
1995; Heinze et al., 2007; Majumdar et al., 2009; Nobles et al., 2012; Weiss et al., 
2008). This discrepancy we observed may result from our electrophysiological 
assay being less sensitive for cells types that exhibit a low glycinergic sIPSC 
frequency. It is also important to take into consideration the global loss of GlyRs in 
these KO models. Some glycinergic ACs express GlyRα2 and others may also 
express GlyRα4 rendering contrasting electrophysiological results of our ON SAC 
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analysis while using global KOs. Considering the established expression of 
GlyRα4 on ON SACs, our demonstration of GlyRα2 and GlyRα4 puncta expression 
on ON SACs, and our electrophysiological evidence of GlyRα2-mediated sIPSCs 
from ON SACs, we conclude they express GlyRα2 and likely express GlyRα4. 
The displaced ON SACs synaptically connect to the dendrites of the ON 
sublamina of the ON/OFF direction selective RGCs, and release GABA to facilitate 
direction selectivity (Rivlin-Etzion, Wei, & Feller, 2012; Wei & Feller, 2011; Wei, 
Hamby, Zhou, & Feller, 2011). Experiments blocking GlyR activity indicate GlyRs 
do not affect direction selectivity (Caldwell & Daw, 1978; Caldwell et al., 1978). 
Nevertheless, GlyR expression of two different GlyRs in ON SACs suggest the 
implicit need for inhibitory regulation to maintain the timing of GABA release. 
Further investigation is required to determine the explicit roles GlyRα2 and GlyRα4 
perform in modulating the output of ON SACs. Experiments assessing the 
spatiotemporal visual response properties of these cells in WT, Glra2-/-, Glra4-/-, 
and Glra2-/-/Glra4-/- will help indicate, through a loss of function approach, the 
individual roles of these GlyRs in ON SACs.  
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CHAPTER IV 
GLYCINE RECEPTOR SUBUNIT EXPRESSION IN MOUSE RETINAL ON-OFF 
DIRECTION SELECTIVE GANGLION CELLS 
INTRODUCTION 
 
In the retina, inhibition is mediated by both γ-aminobutyric acid (GABA)ergic 
and glycinergic neurotransmission. Like the GABA receptor, glycine receptors 
(GlyRs) are heteropentameric chloride ion channels comprised of β and α subunits 
in a stoichiometry of 3β:2α. There is only one β subunit, but there are four different 
α subunits (α1, α2, α3, α4) making four different GlyRs (Cascio, 2006; Lynch, 
2004). It is clear from the published literature that the four glycine receptor subunits 
(GlyRα1-4) are differentially expressed across the sublaminae of the retina’s IPL 
(Haverkamp, 1995; Nobles et al., 2012; Veruki et al., 2007; Wassle et al., 2009). It 
is also established that retinal cells such as OFF cone BCs and rod BCs express 
GlyRα1, some narrow-field ACs express GlyRα2, while another narrow-filed AC, 
the AII amacrine cell, likely expresses GlyRα3 and or GlyRα1, and the wide-field 
starburst ACs express GlyRα4 (Gill et al., 2006; Haverkamp et al., 2004; Majumdar 
et al., 2009; Weiss et al., 2008). However, cell type-specific GlyR expression on 
retinal ganglion cells (RGCs) is less sufficiently characterized.
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The RGCs represent the culmination of retinal signal processing. They 
process, filter, interpolate, and relay an ever-changing visual scene to the rest of 
the brain. Using spiking signals that arise through the interplay of direct excitatory 
and inhibitory inputs, from bipolar cells (BCs) and amacrine cells (ACs), 
respectively. The RGCs form parallel circuits of information flow that arise in the 
retina and lay the foundation for visual perception. Of the roughly forty different 
RGC types, one of the most prominent types in the mouse retina is the ON/OFF 
direction selective (ooDS) RGC (Baden et al., 2016; Bae et al., 2018; Jacoby & 
Schwartz, 2017; Rivlin-Etzion et al., 2011; Sanes & Masland, 2015), which 
represents about 20% of all RGCs in the mouse retina (Sanes & Masland, 2015). 
The four types of ooDS RGCs each encode motion in one of the four cardinal 
directions. It is clear from the published literature that GABAergic mediated 
inhibition is crucial for both direction selectivity and response sensitivity in all ooDS 
RGCs, and GABAA receptor (GABAAR) activity promotes transient ON and OFF 
responses (Caldwell et al., 1978). However, much less is known about the role of 
glycinergic inhibition on the visual response properties of ooDS RGCs, although in 
the rabbit, intravitreal injections of strychnine, a glycine receptor antagonist, 
reduced ooDS RGC response sensitivity and decreased the timing of the OFF 
responses (Caldwell et al., 1978). In these studies, glycinergic inhibition was 
eliminated throughout the retina and consequently we cannot pinpoint the effects. 
They could result from direct glycinergic inhibition onto the ooDS RGCs or through 
glycinergic inhibition in the circuit(s) that modulate the direct excitatory and/or 
inhibitory inputs to these cells.  
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To determine if ooDS RGCs receive direct glycinergic synaptic input, we 
recorded spontaneous inhibitory postsynaptic currents (sIPSCs) and isolated 
glycinergic sIPSCs using GABAA and GABAC receptor antagonists. All ooDS 
RGCs receive glycinergic synaptic inputs, whose average τdecay is slow, about 
20ms. These slow decay kinetics indicates that synaptic inputs are mediated by 
GlyRα4 or GlyRα2. We tested this idea by eliminating the expression of both alpha 
receptors, using Glra4-/-, Glra2-/- and Glra4-/-/Glra2-/- mouse models. We also 
eliminated GlyRα4 expression using retrogradely transported rAAV-Glra4KD-
shRNA or rAAV-Glra2KD-shRNA, respectively. We confirmed the expression by 
using immunohistochemistry and confocal microscopy. GlyR expression in ooDS 
RGCs is consistent with our electrophysiological assessments.  
MATERIALS AND METHODS 
 
Animals 
We used two reporter lines to target ooDS RGCs. Thyrotropin-releasing 
hormone receptor (TRHR-GFP) retinas express GFP in identified ooDS RGCs with 
a direction preference to posterior motion (Rivlin-Etzion et al., 2011). B6-
Pvalbtm1(cre)Arbr/J/Thy1STP-EYFP(PVCre/Thy1STP) reporter mice express YFP in eight 
different RGCs, including ooDS RGCs representing all four cardinal directions 
(Farrow et al., 2013; Hippenmeyer et al., 2005). Both TRHR and PVCre/Thy1STP 
mice were crossed and backcrossed to Glra2-/-, Glra4-/-, and Glra2-/-/4-/- to obtain 
GlyR global knockout models with labeled RGCs. All experiments were carried out 
in accordance with the Association for Research in Vision and Ophthalmology 
(ARVO) Statement for the Use of Animals in Ophthalmic and Visual Research and 
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with the approval of the Institutional Animal Care and Use Committee (IACUC) of 
the University of Louisville. 
Viral Vector Construction and rAAV Production 
To eliminate glycine receptor expression in the ooDS RGCs only, we used 
a retrogradely transported rAAV virus containing shRNAs to Glra4. This approach 
was used previously to knockdown expression of Glra1 (Zhang et al. 2014). Briefly, 
we used our rAAV-Glra1-shRNA, an rAAV virus containing the shRNA Glra1, and 
switched out the shRNA target of Glra1 for Glra4 (29mer in the pGFP-V-RS vector, 
Origene, Rockville, MD). The new plasmid included: flanking Inverted terminal 
repeats, elongation factor-1 promoter, a tdTomato gene with a nuclear localization 
sequence, woodchuck hepatitis post-transcriptional regulatory element, a 
polyadenylation site to protect the mRNA from degradation, the H1 promoter and 
the Glra4-shRNA cassette (Figure 4.1). The plasmids were packaged into the 
recombinant 2/7 rAAV vector serotype using a standard triple-plasmid protocol by 
co-transfection of HEK293T cells to create the rAAV-Glra4KD-shRNA (Grieger, 
Soltys, & Samulski, 2016; McClements & MacLaren, 2013; Reid & Lipinski, 2018). 
The creation of these plasmids was performed by the Gregg Lab (University of 
Louisville, Louisville, KY), and the virus was packaged by the Lipinski (Medical 
College of Wisconsin, Milwaukee, WI), or Roska Labs (Friedrich Miescher Institute, 
Basel Switzerland) labs. 
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Figure 4.1. Schematic diagram of plasmid delivered via rAAV, used to change the 
expression of GlyRα4 in ooDS RGCs. pAAV-Ef1a-NLStdTomato-H1 with Glra4KD 
shRNA (rAAV-Glra4KD-shRNA; 3.28x1012 vg/mL). 
 
Viral Injections in SC or dLGN 
The methods to inject rAAV into the dorsal lateral geniculate nucleus 
(dLGN) are published (Zhang et a., 2014). In many mice (aged between P30 and 
P45), we performed rAAV injections into the superior colliculus (SC) instead. Mice, 
were anesthetized using the administration of an intramuscular (IM), 
intraperitoneal (IP) injection of a mixture of ketamine (70mg/kg) (VetaKet, Akorn, 
Lake Forest, IL) and xylazine (12mg/kg) (AnaSed, LLOYD, Shenandoah, IA). Their 
scalps were shaved, heads secured in a stereotaxic with ear cups and a bite bar, 
and their body temperature (37oC) was maintained with a feedback controlled 
heating pad. Eyes were lubricated with 1.3% polyvinyl alcohol and corneas were 
protected with plastic contact lenses. Stereotaxic coordinates (Paxinos & Franklin, 
2004) were used to locate a craniotomy over the SC. A midline incision was made 
in the skin over the skull, and a craniotomy was performed at 0.5 mm anterior and 
0.5 mm temporal to Lambda. A borosilicate glass pipette (interior diameter of 40-
50μm), filled with ~10 µL of Ringer's solution, was positioned over the craniotomy 
and lowered between 800µm and 1200µm from the surface. Ringer’s solution 
consisted of (in mM: 125 NaCl, 2.5 KCl, 2.0 CaCl2, 1.0 MgCl2, 20 D-glucose, and 
1.25 NaH2PO4, and 26 NaHCO3) (Sigma-Aldrich, Burlingame, CA). The SC was 
located when a clear visually evoked response was recorded through the pipette. 
The depth of the SC was recorded, the Ringer’s pipette removed and a second 
pipette (interior diameter of 18-22 µm), filled with 3.0 µL of rAAV diluted in HBSS 
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(titer for each virus used listed in Figure 4.1) and positioned at the same stereotaxic 
coordinates of the Ringer’s pipette. Light responses also were recorded again to 
confirm placement of the rAAV pipette. Using light pressure, 2-2.5μL of rAAV 
solution was injected into the SC and the pipetted removed. The incision was 
closed with skin glue (VetBond, 3M, St. Paul, MN), the animal was given a 
subcutaneous 100 μl dose of Carprofen (1.25 mg/ml) (Putney, Portland, ME) and 
were recovered from anesthesia.  
Wholemount Retinal Preparation for Electrophysiological Recordings 
Four weeks post injection, animals were dark adapted for 30 minutes, given 
an IP injection of a cocktail of ketamine/xylazine (409mg/kg and 54mg/kg, 
respectively) and sacrificed using cervical dislocation. The eyes were enucleated, 
the front of the eye removed and the retinas were incubated in a solution of 
Ringer’s with collagenase (241 units/mL) and hyaluronidase (34.5nM per mL) 
(Worthington Biochemicals, Lakewood, NJ) for 10 minutes to break down and 
remove the vitreous attached to the retina. Remaining vitreous was carefully 
removed and retinas were washed 3 times with fresh oxygenated Ringer’s to 
eliminate the enzymes. Then, the retinas were quartered and each piece was 
placed RGC side up onto a cover slip, a harp was placed on top of the retina to 
stabilize it, and the apparatus was placed into a chamber (Cell MicroControls, 
Norfolk, VA) on the stage of the microscope. Wholemounts were continuously 
bathed in oxygenated Ringer’s solution at 36°C. The Ringer’s solution was 
preheated to 36o and the exact temperature in the chamber controlled by an NBD 
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TC2 BIP (Bipolar) feedback controller (Cell MicroControls, Norfolk, VA) in the 
chamber. 
Electrophysiological Recordings of RGCs and Pharmacology 
RGCs were visualized on a Nikon Eclipse E600FN microscope with a Nikon 
Fluor 60x water immersion objective with Hoffman Modulation Contrast (Nikon, 
Tokyo, Japan). We targeted fluorescent GFP+ ooDS RGCs in PVCre/Thy1STP or 
TRHR reporter mice and in rAAV infected retinas, we targeted double labeled 
ooDS RGCs; GFP+ (green) from the reporter gene and tdTomato+ (red) nuclei 
from rAAV infection. Glass electrodes were pulled from Kwik-Fil borosilicate glass 
capillaries (1B150F-4, World Precision Instruments, Sarasota, FL) on a P-97 
Flaming/Brown micropipette puller (Sutter Instruments, Novato, CA). The 
resistance of these glass electrodes was 5-7 MΩ. Electrodes were filled with an 
intracellular solution that consisted of: (in mM) 12.5 CsCl, 107 CsOH, 107 D-
Gluconic Acid, 10 Na+ HEPES, 10 BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP 5 
lidocaine N-ethyl bromide (QX314-Br) (Sigma-Aldrich, St. Louis MO), 2.2 Lucifer 
yellow (Fisher Scientific, Hampton, NH) or 12.4 neurobiotin (Vector Labs, 
Burlingame, CA) (pH 7.2 adjusted with CsOH).  
After obtaining a gigaohm seal, the membrane was broken with swift 
negative pressure, and the membrane potential (VHold) was held at -60 mV. All 
recordings were sampled at 10 kHz. First, a light emitted diode (LED) was 
positioned 2 cm above the tissue and presented a full field stimulus (3.7E03 R*). 
The stimulation protocol consisted of: a single 30ms light pulse, followed by a 2 
second interstimulus interval (ISI), which was then followed by a five presentations 
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of a 2 second light pulse with a 20 second ISI. The responses to the five, 2 second 
light stimuli were averaged, analyzed using Clampfit software (Molecular Devices, 
San Jose, CA) and used to determine if the RGC had an ON/OFF response.  
We then characterized the sIPSCs in each ooDS RGC. The cell membrane 
potential was held at +15 mV, the cation reversal potential, and total sIPSCs 
(GABAergic and glycinergic) were recorded for 100 seconds and the membrane 
potential lowered back to -60 mV. GABAA and GABACR antagonists (picrotoxin 
(PTX) [20 μM], and (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphonic acid 
(TPMPA) [50 μM], respectively) were added to the bath solution (Ringer’s) for ten 
minutes to isolate glycinergic sIPSCs. The RGC membrane potential was raised 
to +15 mV and isolated glycinergic sIPSCs recorded for 100 seconds. To verify 
that we had isolated glycinergic sIPSCs, the GlyR antagonist (strychnine 
(STRYCH) [10 μM]) was added to the bath containing the GABA antagonists and 
5 minutes later the cell was held at +15 mV for 100 seconds. Residual sIPSCs 
were never recorded in the presence of GABA and GlyR antagonists.  
Signal was monitored and recorded using an Axon Multiclamp 700B patch 
clamp amplifier (Molecular Devices, San Jose, CA). The signals were digitized at 
10 kHz using an Axon Digidata 1322A and visualized using Clampex 10.2 software 
(Molecular Devices, San Jose, CA). To isolate sIPSCs, RGCs were held at the 
cation reverse potential (VHold) of +15 mV (0mV after correcting for the liquid 
junction potential).  
Electrophysiological Data Analysis 
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We used Mini Analysis software (Synaptosoft, Decatur, GA) to identify 
sIPSCs in ooDS RGCs. First, we selected candidate sIPSC peaks whose 
amplitude exceeded a minimum threshold of twice the root mean squared (RMS) 
of the noise in each recording (between 1.5 and 5 pA). All the sIPSCs selected 
were used to evaluate the frequency (events/sec) for the 100 second recording. 
Next, these sIPSCs were further evaluated using a model sIPSC with a fast rise 
time (10-90% peak, 1-6 ms), a single peak, and a single exponential decay time 
(peak to 37% of peak (D37), 2-120 ms). Double or multi-peaked sIPSCs were only 
in included in the frequency measurement; they were subsequently eliminated 
because their kinetics and amplitude measurements are unreliable. The remaining 
single peak sIPSCs were used in the analyses of the rise time, τdecay, and 
amplitude of the sIPSCs. SIPSCs were never found in our +15 mV recordings with 
both GABA and GlyR antagonists in the bath.  
Immunohistochemistry and Confocal Imaging 
After patch clamp recording, the pieces of retina with recorded and filled 
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12 
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and 
placed into a 24-well plate. Retina pieces were incubated in blocking solution 
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or 
goat) for 60 minutes. Each retina piece was then reacted with a combination of 
primary antibodies to stain for the either GlyRα2or GlyRα4 or a combination of 
both, and Lucifer yellow overnight at 4°C (Table 4.1). In the case where the Lucifer 
yellow antibody was not compatible, streptavidin was used to stain for the filled 
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cell, but was added with the secondary antibodies. The single GlyR antibody or 
combination of GlyR antibodies were selected based on our observed τdecay 
estimates that we matched with the τdecay estimates from the literature (Table 4.1) 
(Haverkamp et al., 2004; Heinze et al., 2007; Majumdar et al., 2009; Wassle et al., 
2009). The primary antibodies were washed off by a series of washes with PBX. 
Afterwards, a combination of secondary antibodies and Hoechst stain (or also 
streptavidin) in normal serum was added to label the primary antibodies and left 
on the tissue overnight at 4°C (Table 4.1). The Hoechst stain was used to label the 
DNA in the somas and distinguish between the retina nuclear and plexiform layers. 
The tissue was then washed with PBS and mounted onto a slide and covered using 
Vectashield (Vector Labs, Burlingame, CA) clear mounting medium and a 
coverslip. 
 
Table 4.1. Primary and Secondary Antibodies used for Immunohistochemistry 
Primary Antibodies Concentration Host Manufacturer 
anti-Lucifer Yellow  1:1000 rabbit polyclonal Life Technologies 
anti-GlyRα2 1:50 goat polyclonal Santa Cruz Biotech 
anti-GlyRα4 1:100 rabbit polyclonal Chemicon 
Secondary Antibodies Concentration Host Manufacturer 
anti-goat IgG Cy3 1:200 donkey polyclonal Jackson ImmunoResearch 
anti-rabbit IgG 488 1:200 donkey polyclonal Jackson ImmunoResearch 
streptavidin Cy2 or 633 1:200 conjugate Life Technologies 
Hoechst nuclear stain 1:1000 conjugate Life Technologies 
 
The recorded and filled ooDS RGCs were imaged using an Olympus 
FV1000 confocal microscope. Whole RGC images were acquired using a 40x 
water immersion (NA 1.15) objective and dendrites and GlyR puncta expression 
were acquired using a 60x oil immersion (NA 1.4) objective. Images of ooDS RGC 
dendrites were recorded with Fluoview software (Olympus, Tokyo, Japan). The 
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depths of the RGC’s dendritic ramifications were measured relative to the top of 
the RGC layer and the bottom of the INL. The combination of each RGC’s dendritic 
ramification depth, dendrite arbor diameter, and light response were used to 
identify and verify that the RGC was an ooDS RGC. 
Colocalization Analysis of GlyRs on ooDS RGCs 
 Expression of GlyRs were characterized in recorded/filled ooDS RGCs. 
Images of ooDS RGC dendrites and GlyR puncta were deconvolved, using 
constrained iterative deconvolution in cellSens (Olympus, Tokyo, Japan). Using 
the Imaris (Bitplane, Zurich, Switzerland) co-localization tool, coincident GlyR 
puncta (color channel 1) on or within dendritic processes (color channel 2) were 
counted and the length of the dendritic processes within the image was measured 
using the filaments tool. The coincident puncta divided by the dendritic length 
estimated puncta density. To determine which puncta were colocalized onto the 
dendrite, the puncta channel (channel 1) was flipped along the xy axis and 
coincident GlyR puncta were recounted. Then, the “flipped” or chance (RAN) 
puncta density was subtracted from the “original” (ORI) puncta density and the 
result estimated the “corrected” puncta density.  
Statistical Analysis 
The data of the sIPSCs from each cell was grouped with like cells and 
pharmacological conditions. The cumulative distribution of the τdecay of the sIPSCs 
of these groups were compared using the Kolmogorov–Smirnov test. The mean 
τdecay, rise time, frequency, and amplitude data of the sIPSCs of these groups were 
compared using a one-way Analysis of Variance, with a Bonferroni Post-Hoc test 
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to compare the data for each cell type or the pharmacological condition or 
genotype in which it was recorded. The Glra2-/-/Glra4KD data was compared to the 
Glra4-/-/Glra2-/- using a Two-tailed Mann-Whitney test. The ORI and RAN puncta 
density counts were compared using a paired Wilcoxon matched–pairs t-test. 
Finally, the corrected puncta density among three groups was compared using a 
Kruskal-Wallis One Way ANOVA test. 
RESULTS 
 
sIPSCs Indicate ooDS RGCs Express GlyRα2 and/or GlyRα4  
We examined the glycinergic isoform specific expression and sIPSCs in 
ooDS RGCs, which were identified by their GFP expression in either TRHR or 
PVCre/Thy1STP mouse lines. We identified ooDS RGCs as GFP+ medium-sized 
soma (~15μm in dia.) RGCs with ON/OFF light evoked responses and bistratified 
dendritic sublamina. In WT ooDS RGCs, the total sIPSCs (Figure 4.2Ai, sIPSCs) 
were a mixture of very slowly decaying, large amplitude sIPSCs and smaller 
amplitude rapidly decaying sIPSCs. In the presence of strychnine, the GABAergic 
sISPCs consisted of large rapid rise, slow decaying currents (Figure 4.2Aii, GABA 
sIPSCs). In the presence of GABAR antagonists (picrotoxin and TPMPA) the large, 
slow currents were eliminated (Figure 4.2Aiii, GlyR sIPSCs) and the isolated 
glycinergic sIPSCs had a mean frequency of 5.7±0.4 events/sec, an average rise 
time of 3.2±0.2 ms, a mean amplitude of 61.4±3.8 pA, and their average τdecay was 
21.7±0.4 ms (Figure 4.2C). In the presence of both GABAR antagonists and 
strychnine, all sIPSCs were eliminated (Figure 4.2Aiv, no sIPSCs), confirming that 
the sIPSCs recorded in the presence of only GABA antagonists were isolated 
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glycinergic sIPSCs. The average τdecay is significantly slower than either GlyRα1 
or GlyRα3 (Figure 4.2B,D,E), which we determined in other studies (see Chapter 
3) and were ~3.0 ms and ~9.0 ms, respectively. The slow τdecay of the GlyR sIPSCs 
in WT ooDS RGCs suggests that they are mediated by GlyRα2 and/or GlyRα4 
isoforms.  
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Figure 4.2. WT ooDS RGC Glycinergic sIPSCs are Slow and are Likely Mediated 
by GlyRα4. A) Raw traces of sIPSCs (red asterisks = GABAergic sIPSC, blue 
asterisks = glycinergic sIPSC)(Ai), isolated GABAergic sIPSCs in the presence of 
STRYCH (Aii), isolated glycinergic sIPSCs in the presence of PTX/TPMPA (Aiii), 
and total block of sIPSCs in the presence of PTX/TPMPA/STRYCH (Aiv) in WT 
ooDS RGCs. GABA sIPSCs were isolated in the presence of STRYCH, GlyR 
sIPSCs were isolated in the presence of PTX/TPMPA, and all sIPSCs were 
eliminated in the presence of PTX/TPMPA/STRYCH. B) Normalized average 
glycinergic sIPSC of WT ooDS RGCs (black), ONα RGCs (grey), W3Glra1KD 
(green) (See Chapter 3). C) WT ooDS RGC mean frequency (5.7±0.4 
events/sec) (Ci), rise time (3.2±0.2 ms) (Cii), amplitude (61.4±3.8 pA) (Ciii), and 
τdecay (22.3±0.6 ms) (Civ). D) Distribution of WT ooDS RGC glycinergic sIPSC 
τdecay times. E) Cumulative distribution of glycinergic sIPSC τdecay times in WT 
ooDS RGCs (black) and ONα RGCs (grey).  
 
ooDS RGCs Express GlyRα4-Positive Puncta 
 As an independent measure of subunit specific expression, we assessed 
GlyRα4 positive puncta on the ooDS RGC dendrites and compared the density to 
an estimate of random puncta coincidence. The average ooDS GlyRα4-positive 
puncta density was 0.15±0.02 puncta∙μm-1, which was significantly more than the 
random GlyRα4-positive puncta density, which was 0.11±0.01 puncta∙μm-1 (Figure 
4.3B,D p < 0.0004 (paired one-tailed T-test). When corrected for our estimate of 
randomly associated GlyRα4-positive puncta, the corrected density of GlyRα4 
puncta expression on ooDS RGCs was 0.04±0.01 puncta∙μm-1 (Figure 4.3D). This 
corrected GlyRα4-positive puncta value suggest positive expression of GlyRα4 on 
ooDS RGCs. GlyRα4 expression is absent in the Glra4-/- retina (Nobles et al., 
2012). 
We also assessed GlyRα2 positive puncta on the ooDS RGC dendrites and 
compared the density to an estimate of random puncta coincidence. The average 
ooDS RGC GlyRα2-positive puncta density was 0.30±0.09 puncta∙μm-1, which was 
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similar to the random GlyRα2-positive puncta density, which was 0.21±0.06 
puncta∙μm-1 (Figure 4.3C,E, p > 0.05 (paired one-tailed T-test). When corrected 
for our estimate of randomly associated GlyRα2-positive puncta, the corrected 
density of GlyRα2 puncta expression on ooDS RGCs was 0.09±0.08 puncta∙μm-1 
(Figure 4.3E). The similarity between the GlyRα2-positive puncta and chance 
puncta coincidence suggests GlyRα2 expression is absent on ooDS RGCs. 
GlyRα2 expression is absent in the Glra2-/- retina (Nobles et al., 2012). 
 
Figure 4.3. ooDS RGCs Express GlyRα4 Puncta. (Images and data sourced from 
(C. Zhang, 2015). A) Whole mounted En Face image of ooDS RGC filled with 
neurobiotin (scale bar: 40μm). B) Wholemount image of ooDS RGC dendrites (Bi 
– ON sublamina, Bii – OFF sublamina) stained for GlyRα4 expression (red) 
(scale bar: 5μm). White arrows indicate representative co-localization of GlyRα4. 
C) Wholemount image of ooDS RGC dendrites (Ci – ON sublamina, Cii – OFF 
sublamina) stained for GlyRα2 expression (red) (scale bar: 5μm). White arrows 
indicate representative co-localization of GlyRα2. D) Dendrites in WT ooDS 
RGCs have significantly more GlyRα4 puncta density co-localization (μm-1) than 
coincidence co-localization in the flipped (RAN) orientation (Wilcoxon Matched-
pairs T-test, p value < 0.006). The corrected puncta density for GlyRα4 puncta on 
ooDS RGCs is 0.04±0.01 μm-1(4 cells, 10 dendritic areas). E) Dendrites in WT 
ooDS RGCs do not show significantly more GlyRα2 puncta density co-
localization (μm-1) than coincidence co-localization in the flipped (RAN) 
orientation (Wilcoxon Matched-pairs T-test, p value < 0.563). The corrected 
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puncta density for GlyRα2 puncta on ooDS RGCs is 0.09±0.08 μm-1 (3 cells, 6 
dendritic areas) 
 
GlyRα2-Mediated Synaptic Inputs Remain in Glra4-/- ooDS RGCs 
To test the hypothesis that the ooDS RGCs express GlyRα4, we recorded 
glycinergic sIPSCs in Glra4-/- ooDS RGCs and found that the glycinergic sIPSC 
frequency was 5.8±0.7 events/sec, which was similar to WT (Figure 4.4C; p > 
0.05). In the presence of strychnine, all ooDS RGC glycinergic sIPSCs were 
eliminated in the Glra4-/- indicating these were indeed GlyR-mediated. We 
characterized the glycinergic sIPSCs in the Glra4-/- to determine what other GlyR 
α subunit is expressed and mediates these slow glycinergic synaptic currents. The 
Glra4-/- ooDS glycinergic sIPSCs had a mean rise time of 3.4±0.4 ms and were 
similar to WT (Figure 4.4D, p > 0.05). The ooDS RGC glycinergic sIPSC mean 
amplitude was 56.9±8.0 pA, which was similar to WT (Figure 4.4E, p > 0.05). The 
glycinergic sIPSCs in the Glra4-/- ooDS RGCs had a mean τdecay of 23.5±1.8 ms, 
which was also similar to WT (Figure 4.4F,G, p > 0.05). However, the τdecay 
cumulative distribution of glycinergic sIPSCs of the Glra4-/- ooDS RGCs was 
significantly different from WT and the curve was shifted to the right (Figure 4.4F, 
Kolmogorov–Smirnov test p < 4.3e-5). Considering the GlyRα4 puncta expression 
and the shift of the glycinergic sIPSC τdecay curve indicate GlyRα4 may be 
expressed on ooDS RGCs, but the similar sIPSC frequency and kinetics led us to 
hypothesize the majority of the glycinergic sIPSCs are mediated by GlyRα2. 
Slow Glycinergic-Mediated sIPSCs Remain in the Glra2-/- ooDS RGCs  
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We tested the hypothesis that GlyRα2 receptors mediate synaptic currents 
in ooDS RGCs, and recorded from these cells in Glra2-/- retinas. Surprisingly, the 
frequency of glycinergic sIPSCs in Glra2-/- ooDS RGCs was 6.3±0.4 events/sec 
and was similar to both WT and Glra4-/- (Figure 4.4C; p > 0.05). In the presence of 
strychnine, the glycinergic sIPSCs were eliminated, demonstrating they are GlyR-
mediated. The average rise time of the remaining glycinergic sIPSCs in the Glra2-
/- ooDS RGCs was 3.5±0.2 ms and was similar to both the WT and Glra4-/- (Figure 
4.4D, p > 0.05). The mean amplitude of the Glra2-/- ooDS RGC glycinergic sIPSCs 
was 80.1±9.5 pA, and was similar to WT and Glra4-/- (Figure 4.4E, p > 0.05). The 
average Glra4-/- ooDS RGC glycinergic sIPSC τdecay was 20.3±0.6 ms, which was 
also similar to WT and Glra4-/- in the absence of GlyRα2 (Figure 4.4F,G, p > 0.05). 
However, the cumulative glycinergic sIPSC τdecay curve differed significantly from 
both WT and Glra4-/- (Figure 4.4F, Kolmogorov–Smirnov test, p < 0.02 (Glra2-/- vs. 
WT) and p < 2.6e-04 (Glra2-/- vs. Glra4-/-). Considering the contention of eliminating 
GlyRα2 or GlyRα4 and observing no loss of glycinergic sIPSC frequency in ooDS 
RGCs, like we observe in other multi-subunit glycine receptor expression cells (see 
Chapter 3), we examined the glycinergic sIPSCs in a double KO model (Glra4-/-
/Glra2-/-). 
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Figure 4.4. ooDS RGCs express both GlyRα2 and GlyRα4 A) Raw traces of 
sIPSCs (Ai), GlyR sIPSCs isolated in the presence of PTX/TPMPA (Aii), and 
eliminated sIPSCs in the presence of PTX/TPMPA/STRYCH (Aiii) in Glra2-/-, 
Glra4-/- and Glra2-/-/Glra4-/- ooDS RGCs. B) Average glycinergic sIPSC trace of 
Glra4-/- (red), Glra2-/- (Blue), and Glra2-/-/Glra4-/- (purple) ooDS RGCs C) Mean 
frequency (events/sec) of glycinergic sIPSCs in ooDS RGCs: WT (5.7±0.4), 
Glra4-/- (5.8±0.7),Glra2-/- (6.3±0.4), Glra2-/-/Glra4-/- (1.1±0.2). Glra2-/-/Glra4-/- GlyR 
sIPSC frequency is significantly less than WT or single KOs (One-way Analysis 
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of Variance, Bonferroni Post-Hoc test, **** p value < 0.0001). D) Average rise 
times of ooDS RGC glycinergic sIPSCs in WT (3.2±0.2 ms), Glra4-/- (3.4±0.1 ms), 
Glra2-/- (3.5±0.2 ms), and Glra2-/-/Glra4-/- (3.4±0.4 ms) are all similar (One-way 
Analysis of Variance, Bonferroni Post-Hoc test, p value > 0.05). E) Average 
amplitude of ooDS RGC glycinergic sIPSCs in: WT (61.4±3.8 pA), Glra4-/- 
(56.1±9.0 pA), Glra2-/- (93.4±15.9 pA), and Glra2-/-/Glra4-/- (31.4±4.7 pA). Glra2-/-
/Glra4-/- was significantly less than both WT and Glra2-/- (One-way Analysis of 
Variance, Bonferroni Post-Hoc test, * p value < 0.05, *** p value < 0.001). F) 
Cumulative distribution of GlyR sIPSC τdecay in ooDS RGCs: WT (black), Glra4-/- 
(red), Glra2-/- (blue), Glra2-/-/Glra4-/- (purple). Glra2-/-/Glra4-/- GlyR sIPSC τdecay is 
significantly faster than WT and both single KOs (Kolmogorov–Smirnov test). G) 
The mean τdecay of ooDS RGC glycinergic sIPSCs was similar among: WT 
(22.3±0.6 ms), Glra4-/- (23.5±1.8 ms) Glra2-/- (20.3±0.6 ms), and Glra2-/-/Glra4-/- 
(11.8±1.5 ms) (One-way Analysis of Variance, Bonferroni Post-Hoc test, * p 
value > 0.05). 
 
Glra4-/-/Glra2-/- Eliminates 80% of the Glycine-Mediated Synaptic Inputs in ooDS 
RGCs 
 To test the hypothesis that ooDS RGCs express both GlyRα4 and GlyRα2, 
we recorded glycinergic sIPSCs in these cells using Glra4-/-/Glra2-/-/TRHR mouse 
retinas. The Glra4-/-Glra2-/- ooDS RGC frequency of glycinergic sIPSCs was 
1.1±0.2 events/sec, which was significantly less than WT, Glra4-/- and Glra2-/- 
(Figure 4.4C, p < 0.0001). This significant reduction in glycinergic sIPSC frequency 
indicates ooDS RGCs express both GlyRα2 and GlyRα4. However, some 
glycinergic sIPSCs remain in the Glra4-/-Glra2-/- ooDS RGCs, and these were 
eliminated in the presence of strychnine (Figure 4.4Aiii). We examined the 
remaining glycinergic sIPSCs and found the average rise time of 3.4±0.4 ms was 
similar to WT, Glra2-/-, and Glra4-/- (Figure 4.4D, p > 0.05). The average glycinergic 
sIPSC amplitude of ooDS RGCs in the Glra4-/-/Glra2-/- was 31.4±4.7 pA, which was 
significantly less than both WT and Glra2-/-, but similar to Glra4-/- (Figure 4.4E, p < 
0.001). The mean τdecay of the remaining glycinergic sIPSCs in the Glra4-/-/Glra2-/- 
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ooDS RGCs was 11.8±1.5 ms and significantly less than WT, Glra4-/-, and Glra2-/- 
(Figure 4.4G, p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc 
test). Similarly, the cumulative glycinergic sIPSC τdecay curve differed significantly 
from WT, Glra4-/-, and Glra2-/- (Figure 4.4F, Kolmogorov–Smirnov test, p < 8.08e-
84). The characteristics of the remaining ooDS RGC glycinergic sIPSCs are most 
similar to GlyRα3 currents that we recorded in F-mini RGCs in Glra2-/- retinas, and 
in Glra1KD infected W3 RGCs (see chapter 3) (Table 4.2). Based on these 
comparisons, we conclude that ooDS RGC glycinergic sIPSCs are primarily 
mediated by GlyRα4 and GlyRα2, with ~20% missing arising from GlyRα3-
mediated. 
 
Table 4.2. GlyRα3-Mediated sIPSC Currents. 
RGC Type / Receptor / Model Mean Rise Time (ms) Mean Amplitude (pA) Mean τdecay (ms) 
F-mini / GlyRα3 / Glra2-/-  2.0±0.1 22.4±3.0  7.8±0.4 
W3 / GlyRα3 / Glra1KD 2.5±0.4 26.9±3.1 10.1±1.0 
ooDS / GlyRα3? / Glra4-/-/Glra2-/- 3.4±0.4 31.4±4.7 11.8±1.5 
 
rAAV-Mediated RNAi Reduces the GlyR-mediated sIPSC Frequency in rAAV-
Glra4-shRNA Infected ooDS RGCs 
There are several reasons why the frequency of glycinergic sIPSCs in 
Glra4-/- or Glra2-/- ooDS RGCs is similar to WT (Figure 4.4C). The frequency could 
be maintained if the global absence of one or the other glycine receptor enhances 
presynaptic glycine release onto the ooDS RGCs. There is also the possibility that 
expression of each of these receptors could be upregulated in the absence of the 
other, although we previously found no evidence for upregulation (Nobles et al., 
2012). The WT GlyR receptor could be a heteromer containing both α4 and α2 
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subunits with a stoichiometry of (3β:1α4:1α2). In this case, when either GlyRα4 or 
GlyRα2 expression was eliminated the remaining GlyR receptor would simply be 
composed of the typically observed GlyR2α (3β:2α). There could be a fifth 
unknown glycine receptor alpha subunit, although this is unlikely because only four 
different α subunit genes are known from genetic screening.  
To begin to distinguish among these possible scenarios, we eliminated 
expression of each receptor subunit selectively in only RGCs (as opposed to a 
global knockout) using an approach in which a retrogradely transported rAAV 
shRNA knocks down GlyR expression (C. Zhang et al., 2014). We first targeted 
double-labeled YPF positive ooDS RGCs with red nuclei in the rAAV-Glra4KD-
shRNA injected TRHR mice. In these infected cells expressing Glra4KD-shRNA, 
the average frequency of glycinergic sIPSCs was 2.6±0.5 events/sec and was 
significantly reduced compared to WT (Figure 4.5B; p < 0.0006). This glycinergic 
sIPSC frequency represents a 55% reduction in glycinergic activity. Interestingly, 
the average rise time became slower at 4.6±0.3 ms than both WT and Glra4-/- 
(Figure 4.5C, p < 0.0001). The mean amplitude of glycinergic sIPSCs in the 
Glra4KD-shRNA was 28.5±3.7 pA and was significantly lower than both WT and 
Glra4-/- (Figure 4.5D, p < 0.0009). The average τdecay was 20.2±1.1 ms, which was 
similar to WT and Glra4-/- (Figure 4.5F, p > 0.05). The cumulative distribution curve 
of the glycinergic sIPSC τdecay of the Glra4KD-shRNA infected ooDS RGCs was 
significantly different from both WT and Glra4-/- (Figure 4.5E, Kolmogorov–Smirnov 
test, p < 5.9e-11). A reduced frequency and amplitude in the Glra4KD-shRNA 
infected ooDS RGCs suggests the synapses express fewer GlyRs overall. The 
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slow average τdecay suggests that the majority of the remaining glycinergic sIPSCs 
are mediated by GlyRα2. To evaluate the effectiveness of rAAV-Glra4KD-shRNA, 
we then recorded glycinergic sIPSCs from ooDS RGCs in rAAV-Glra4KD-shRNA in 
the Glra2-/-/TRHR mouse model. We hypothesized the sIPSCs in this experiment 
would be similar to the Glra4-/-/Glra2-/- and have some remaining sIPSCs with a 
lower amplitude and a faster τdecay. 
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Figure 4.5. rAAV-Glra4KD-shRNA reduces the frequency of glycinergic sIPSCs in 
ooDS RGCs. A) Raw traces of rAAV-Glra4KD infected ooDS RGC glycinergic 
sIPSCs in cntl. bath (Ai), in the presence of PTX/TPMPA (Aii), and in 
PTX/TPMPA/STRYCH (Aiii). B) The mean frequency (events/sec) of glycinergic 
sIPSCs in ooDS RGCs was significantly lower in Glra4KD: WT (5.9±0.4), Glra4-/- 
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(5.8±0.7), Glra4KD (2.2±0.4) (p value < 0.0025 One-Way Analysis of Variance, 
Bonferroni Post-Hoc test) C) Mean rise time (ms) of glycinergic sIPSCs in ooDS 
RGCs in WT (3.2±0.4 ms), Glra4-/- (3.4±0.1 ms), and Glra4KD (4.6±0.3 ms). 
Glra4KD is significantly higher than both WT and Glra4-/- (p value < 0.001 One-
Way Analysis of Variance, Bonferroni Post-Hoc test). D) The mean amplitude of 
ooDS RGC glycinergic sIPSCs was significantly less in Glra4KD: WT (61.4±3.8 
pA), Glra4-/- (56.1±9.0 pA), and Glra4KD (28.1±4.3 pA) (p value < 0.0009 One-
Way Analysis of Variance, Bonferroni Post-Hoc test). E) Cumulative distribution 
of GlyR sIPSC τdecay in ooDS RGCs: WT (black), Glra4-/- (red), rAAV-Glra4KD-
shRNA (pink). Glra4KD τdecay distribution is no different than WT or Glra4-/- 
(Kolmogorov–Smirnov test). F) Mean glycinergic sIPSC τdecay of WT, Glra4-/-, and 
rAAV-Glra4KD-shRNA infected ooDS RGCs were all similar (p > 0.05, One-Way 
Analysis of Variance, Bonferroni Post-Hoc test). G) Raw traces of Glra2-/- + 
rAAV-Glra4KD infected ooDS RGC glycinergic sIPSCs in cntl. bath (Gi) and in 
PTX/TPMPA (Gii), and in PTX/TPMPA/STRYCH (Giii). H) The mean frequency 
(events/sec) of glycinergic sIPSCs in ooDS RGCs was similar between: Glra2-/-
/Glra4-/- (1.2±0.2) and Glra2-/- + rAAV-Glra4KD infected ooDS RGCs (1.6±0.6) (p > 
0.05, One-Way Analysis of Variance, Bonferroni Post-Hoc test). I) Mean Rise 
time (ms) of glycinergic sIPSCs in ooDS RGCs in Glra2-/-/Glra4-/- (3.4±0.4 ms) 
and Glra2-/- + rAAV-Glra4KD (4.3±0.4 ms), was similar (p > 0.05, One-Way 
Analysis of Variance, Bonferroni Post-Hoc test). J) The mean amplitude of ooDS 
RGC glycinergic sIPSCs was similar between: Glra2-/-/Glra4-/- (31.4±4.7 ms) and 
Glra2-/- + rAAV-Glra4KD (31.0±10.1 ms) (p > 0.05, One-Way Analysis of Variance, 
Bonferroni Post-Hoc test). K) Cumulative distribution of GlyR sIPSC τdecay in 
ooDS RGCs: Glra2-/-/Glra4-/- (purple) and Glra2-/- + rAAV-Glra4KD (light blue). The 
Glra2-/- + rAAV-Glra4KD glycinergic sIPSC τdecay is significantly shifted to the right 
of Glra2-/-/Glra4-/- (Kolmogorov–Smirnov test). (L) The mean glycinergic sIPSC 
τdecay of Glra2-/- + rAAV-Glra4KD (20.3±2.1 ms) is significantly slower than Glra2-/-
/Glra4-/- (11.8±1.5 ms) (p < 0.05, One-Way Analysis of Variance, Bonferroni Post-
Hoc test). 
 
rAAV-Mediated RNAi in Glra2-/- ooDS RGCs Eliminates GlyRα4-Mediated 
sIPSCs in rAAV-Glra4-shRNA Infected ooDS RGCs 
In Glra2-/- ooDS RGCs infected with the Glra4KD-shRNA, the frequency of 
glycinergic sIPSCs was 1.6±0.7 events/sec, which was similar to the frequency 
recorded in Glra2-/-/Glra4-/- (Figure 5H, p > 0.05). The rise time of the infected ooDS 
RGCs was 4.5±0.4 ms and similar to the rise time of the double knockout (Figure 
5I, p > 0.05). The mean amplitude of the glycinergic sIPSCs in the Glra4KD-shRNA 
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infected Glra2-/- ooDS RGCs was 33.7±11.3 pA and was also similar to the Glra2-
/-/Glra4-/- model (Figure 5J, p > 0.05). Surprisingly, the glycinergic sIPSC τdecay 
cumulative distribution of the Glra4KD-shRNA infected Glra2-/- ooDS RGCs was 
significantly slower than the double knockout (Figure 5K, Kolmogorov–Smirnov 
test, p < 6.8e-97). Correspondingly, the glycinergic sIPSC mean τdecay of the 
Glra4KD-shRNA infected Glra2-/- ooDS RGCs was 21.7±1.8 ms and significantly 
slower than the Glra4-/-/Glra2-/- (4.5L, p < 0.0007). The glycinergic sIPSC 
frequency, rise time, and amplitude data suggest the Glra4KD-shRNA infected 
Glra2-/- ooDS RGCs are identical to Glra4-/-/Glra2-/- ooDS RGCs. In contrast, the 
glycinergic sIPSC τdecay of the Glra4KD-shRNA infected Glra2-/- ooDS RGCs was 
significantly slower than Glra4-/-/Glra2-/- ooDS RGCs. The most likely explanation 
is that a developmental difference occurs when these RGCs lack glycinergic 
receptors from birth.  
DISCUSSION 
 
We demonstrated that WT ooDS RGCs receive synaptic glycinergic inputs 
and that these inputs are mediated by postsynaptic GlyRs with slow decay kinetics. 
Previous studies have shown that the α subunit of the GlyR is responsible for the 
decay kinetics of the synaptic inputs, the sIPSCs. Furthermore, those studies 
measured the sIPSC τdecay of GlyRα1 as ~3 ms, GlyRα3 as ~ 10 ms, GlyRα2 as 
~27 ms, and GlyRα4 as ~53 ms at room temperature or 25°C (Majumdar et al., 
2007; Majumdar et al., 2009; Wassle et al., 2009). In our analysis of glycinergic 
sIPSCs we estimated both GlyRα4 and GlyRα2 receptors to have a faster τdecay 
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time than the reported results due to the fact that our recording was at the mouse 
core body temperature of 36°C, which likely represents in vivo physiological GlyR 
kinetics. We then tested our hypothesis that WT ooDS RGCs express either 
GlyRα4 or GlyRα2 using immunohistochemistry and stained for GlyR α subunit 
specific-mediated puncta. Our findings confirmed GlyRα4 is expressed on ooDS 
RGCs, but were inconclusive of their expression of GlyRα2. Using Glra4-/- (global 
knockout model) we recorded glycinergic sIPSCs in the ooDS RGCs and found 
the frequency, rise time, amplitude, and mean τdecay similar to WT, and only the 
sIPSC cumulative distribution of τdecay as an indication ooDS RGCs express 
GlyRα4. We then recorded glycinergic sIPSCs in the Glra2-/- and also found them 
to be similar to WT. Only when we recorded glycinergic sIPSCs from Glra4-/-/Glra2-
/- did we see a significant reduction in sIPSC frequency, which demonstrated WT 
ooDS RGCs express both GlyRα4 and GlyRα2. We also measured the remaining 
sIPSCs and found their mean τdecay to be indicative of GlyRα3 ~10 ms. Further 
investigation is needed to verify that GlyRα4 and GlyRα2 expression is 
accompanied by the expression of GlyRα3 or another GlyR. 
Intrigued by the similarity of the glycinergic sIPSC analysis results of the 
single knockout model of ooDS RGC to the WT model, we recorded ooDS RGCs 
infected with an rAAV-Glra4KD-shRNA and found the frequency of glycinergic 
sIPSCs was reduced. Additionally, we tested the same Glra4KD-shRNA in Glra2-/- 
to verify the effectiveness of the Glra4KD-shRNA. We found that the Glra2-/- + rAAV-
Glra4KD-shRNA infected ooDS RGCs had a similar frequency, amplitude, and rise 
time as the Glra4-/-Glra2-/-. However, the mean τdecay and the cumulative 
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distribution of the τdecay was significantly slower. This is likely due to the imperfect 
efficiency of the Glra4KD-shRNA as observed in Chapter 3 and in (C. Zhang et al., 
2014). Our previous results from using an rAAV with shRNA to knockdown the 
expression of a GlyR were effective but some glycinergic sIPSCs remained (C. 
Zhang et al., 2014). It is likely some GlyRα4 expression remains the Glra2-/- + 
Glra4KD-shRNA knockdown model, though low as mediated by the reduction in 
sIPSC frequency, remaining sIPSCs mediated by this expression may cause the 
τdecay kinetics to be more similar to WT. 
Synapse-Specific Expression of GlyRα2 and GlyRα4 
In RGCs that co-express two or more GlyRs (F-mini, LED, HD, UHD, and 
J-RGC) the global knockout of a single GlyRα showed a reduction of glycinergic 
sIPSC frequency and the remaining sIPSCs demonstrated their standalone 
amplitude and kinetics (See Chapter 3). This result suggests different glycine 
receptor subtypes are expressed at different synapses in the same cell since a 
lower frequency of GlyR sIPSCs indicates less complete synaptic transmission due 
to the entire loss of receptors in a single synapse. However, evaluations of 
glycinergic sIPSCs in Glra2-/- or Glra4-/- in ooDS RGCs showed no change 
frequency or amplitude, which suggested two possibilities: 1) WT ooDS RGCs co-
express GlyRα4 and GlyRα2 in different synapses, and global loss of one of these 
glycine receptors alters inhibition to their presynaptic amacrine cell. This change 
increases glycine release from the amacrine cells and a concomitant increase in 
GlyR sIPSC frequency in the ooDS RGCs, effectively masking the fewer number 
of GlyR synapses. 2) WT ooDS RGCs also co-express GlyRα4 and GlyRα2 in this 
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scenario, however, the loss of one glycine receptor subtype is compensated by the 
expression of the remaining glycine receptor expressed in the cell. Furthermore, it 
is conceivable the trafficking mechanisms for the two GlyRs could be the same, 
and traffic GlyRα2 or GlyRα4 interchangeably because these two GlyRs share a 
91% homology (Matzenbach et al., 1994).  
Scenario one is unlikely because we demonstrated drastic loss of 
glycinergic sIPSC activity in the Glra4-/-/Glra2-/- ooDS RGCs. Splice variants of the 
GlyRα2 subunit have been found in the brain and spinal cord, making this scenario 
important to consider in future investigations (Miller et al., 2004; Oertel, Villmann, 
Kettenmann, Kirchhoff, & Becker, 2007). In the second scenario, the loss of a 
single glycine receptor could affect the downstream release properties of glycine 
vesicles onto ooDS RGCs, and mask the loss of GlyR expression by over-
releasing glycine into synapses with the remaining GlyR. However, GlyRα2, 
GlyRα3, and GlyRα1 are densely expressed throughout the IPL, yet GlyRα4 is 
expressed only in the ON choline Acetyltransferase band in the IPL. (Buldyrev, 
Puthussery, & Taylor, 2012; Demb & Singer, 2012; Eggers & Lukasiewicz, 2006a; 
S. C. Lee et al., 2015; Manookin et al., 2008; Wassle et al., 2009; Weiss et al., 
2008). As a result, to date, GlyRα4 has only been found expressed in the ON SAC 
cells, which are synaptically connected to ooDS RGCs, but do not release glycine 
(S. C. Lee et al., 2015; Menger, Pow, & Wassle, 1998; Pow & Hendrickson, 1999). 
It is unlikely that both single knockouts would similarly affect the downstream AC-
mediated glycine release onto ooDS RGCs because of the differential expression 
of GlyRα2 and GlyRα4. Nevertheless, the ON SACs may express both GlyRα2 
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and GlyRα4 (see Chapter 3), and the global loss of either GlyR may affect a serial 
inhibition connection, which influences glycine release onto the ooDS RGCs. And, 
GlyRα4 and GlyRα2 are kinetically similar. This scenario where glycine release is 
upregulated in the single knockout of either GlyRα4 or GlyRα2 is more likely to 
occur than the existence of a splice variant. However, the feasibility of both single 
KOs affecting glycine release onto the ooDS RGCs in a similar manner is not 
substantial. 
In the third scenario, enough of the remaining GlyR mRNA in a single global 
knockout of another GlyR, is already present and it is translated and trafficked to 
the synapses, which would normally express the knocked out GlyR i.e. 
compensation for the loss of the knocked out GlyR. Or, compensation could occur 
via a more complex mechanism where there is gene overexpression of the 
remaining GlyR. We did successfully demonstrate this scenario is unlikely in our 
experiments using rAAV-Glra4KD-shRNA. In this experiment, the glycinergic 
sIPSC frequency was significantly reduced in rAAV-Glra4KD-shRNA infected WT 
ooDS RGCs. Also, the average GlyR turnover rate is about 20 hours, while in our 
rAAV injection experiments the rAAV-Glra4KD-shRNA was in the retina for up to a 
week before recording (Chow, Zuchowski, & Fetcho, 2017). However, this scenario 
is still the most feasible explanation for our findings because our experiments did 
not account for the upregulation or overexpression of the remaining GlyR in the 
single KO models that could have occurred during development. Our experiments 
should be recapitulated and account for the loss of a GlyR and the possible 
compensation of that loss during development. Furthermore, one could potentially 
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measure the rate of GlyR expression during development in a single KO model 
using qPCR.
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CHAPTER V 
DISCUSSION 
I. GENERAL DISCUSSION 
 
Studying the brain as a vision scientist gives one exposure to almost every 
facet of biomedical research. Researchers from almost every discipline can find a 
way to investigate the visual system. By using the tried and true methods of 
electrophysiology and immunohistochemistry, I successfully managed to add to 
the vast and quickly growing body of knowledge concerning vision. Though these 
methods continue to be the gold standard, vision research is expanding into realms 
likely never fathomed by the great vision scientists such as Barlow and Hill, Enroth-
Cugell and Kuffler. The rapid development of technology and the mixing of 
disciplines has given vision researchers tools to parse out circuits, discover new 
cell types, and model the visual system for artificial intelligence. This field will likely 
continue to expand and will be fascinating to watch from the perspective of a 
scientist. 
CHAPTER III Summary 
We successfully identified much of the GlyRα subunit specific expression in 
a subset of RGCs, which together make up about 50% of the roughly 40,000 retinal 
ganglion cells found in a mouse retina. Collectively, these cells differentially 
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express all four different glycine receptor subtypes in the IPL. The α RGCs express 
GlyRα1, the LED, HD, and UHD RGCs express both GlyR both GlyRα3 and 
GlyRα1, the F-mini RGCs express both GlyRα2 and GlyRα3, the J-RGCs express 
GlyRα2, and the ON SACs likely express both GlyRα4 and GlyRα2. This is a 
comprehensive list of identified RGCs that collectively express each of the four 
GlyRα subunits. This list can now be exploited to investigate the individual roles of 
the different GlyRs within the retina. Furthermore, we developed an assay to 
investigate GlyR expression via a global knockout approach. This approach can 
be used to study other RGCs of interest and discover their GlyR subunit specific 
expression. Future research of retinal inhibitory circuits should evaluate the role of 
glycinergic inhibition at the level of the specific GlyR subunit as opposed to an all-
or-none approach with disregard to subtle differences that avoid new discoveries.  
Though our knockout approach was sufficient in the investigation of some 
of the RGC types, we employed a more powerful tool, the use of two different rAAV 
delivered shRNAs to knock down the expression of Glra1 and Glra4. The 
knockdown experiments are superior to the global knock out experiments for many 
reasons: 1) Only glycine receptors expressed on infected RGCs are knocked 
down. Thus, with synapses and all glycine receptors of the upper circuitry intact, 
measurable changes are not masked or amplified by the loss of glycine receptors 
in other retinal cells. 2) In addition to studying glycine receptor function on retinal 
ganglion cells, knocking down glycine receptor expression also isolates the 
GABAergic receptors allowing for the study of their function. 3) rAAV delivered 
shRNAs allow for precise temporal control of the target gene so the injected animal 
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can mature into adulthood with all inhibitory circuitry and the synapses intact. Then, 
only the glycine receptors are knocked down, potentially preserving glycine release 
properties and the glycinergic synapses in amacrine cells and bipolar cells. 
CHAPTER IV Summary 
While identifying the expression or co-expression of glycine receptors on 
specific ganglion cells, a pattern emerged where the loss of a single glycine 
receptor always resulted in a decrease of GlyR activity. We observed this 
phenomenon by measuring the glycinergic sIPSC frequency in the ONα, ONT, 
OFFα, OFFδ, UHD, LED, HD1, HD2, F-mini, J-RGCs, and the ON SACs. However, 
when measuring the frequency of glycinergic sIPSCs in the ooDS RGCs, the loss 
of a single receptor (either GlyRα2 or GlyRα4), did not result in a decrease of GlyR 
activity. It was not until the double knockout of both co-expressed GlyRα2 and 
GlyRα4 did a significant decrease in glycinergic sIPSC activity occur. In both single 
knockout examples, Glra2-/- or Glra4-/-, the remaining GlyR sIPSC frequency was 
unchanged from WT. The possible mechanisms which explain this abnormality 
are:  
1) The presence of a splice variant of one of the GlyRα subunits, which have 
been found for GlyRα2 and the GlyRβ subunit (Miller et al., 2004; Oertel et al., 
2007). However, the splice variants of GlyRα2 are kinetically identical and their 
presence in the retina would be undetectable using our electrophysiological assay 
(Miller et al., 2004). 
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2) Another possibility is that both GlyRα2 and GlyRα4 are co-expressed in 
the ooDS RGCs. The global knockout of a single GlyRα subunit would result in an 
increase of the glycine release from amacrine cells onto the ooDS RGCs. The 
increase in glycine release would compensate for the loss of the single co-
expressed GlyR and the typical observed decrease in frequency would effectively 
be masked. Since, we observed identical results in both Glra2-/- and Glra4-/-, 
compensation of glycine release from presynaptic ACs would likely be similar. 
However, we know the expression of GlyRα2 and GlyRα4 is differential. 
Furthermore, there is evidence of GlyRα2 expression on narrow-field glycinergic 
amacrine cells. Yet, the only AC known to express GlyRα4 is the wide-field 
starburst AC; which certainly connects synaptically with ooDS RGCs, but it does 
not release glycine. However, the ON SAC could be involved in a serial inhibition 
circuit with a glycinergic amacrine that releases glycine into the inhibitory synapses 
of the ooDS RGCs. If the ON SAC does express both GlyRα4 and GlyRα2, then 
altered GABA release in the proposed serial circuit resulting in either Glra4-/- and 
Glra2-/- could culminate in similar glycinergic sIPSC frequency.  
3) The final scenario is also possible if ooDS RGCs co-express both GlyRα2 
and GlyRα4. In a congenital knockout of a single GlyRα subunit, the remaining 
normally co-expressed GlyR expression is increased to compensate for the loss 
of the knocked out GlyR. In addition to the previous idea is that remaining 
endogenous expression was already high enough to compensate for the loss of 
the co-expressed GlyR. We observed no compensation in the knockdown model 
and furthermore, compensation of any GlyR in a single GlyR KO has not been 
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observed (Nobles et al., 2012). However, our knockdown model does not take into 
account the possibility of compensation of the remaining GlyR in the single GlyR 
KO during development. Further study is needed to verify this more plausible 
scenario including both a developmental study, and the measurement of mRNA 
expression of GlyRs in ooDS RGCs during development in WT and single KO 
models, and after the infection of an rAAV-Glra4KD-shRNA. 
After we identified the GlyR co-expression of GlyRα2 and GlyRα4 on ooDS 
RGCs, we set out to identify the mechanism in which these cells successfully 
maintain their glycinergic sIPSC frequency after a single GlyR knockout. We 
employed the rAAV delivered shRNA method to knock down the expression of 
GlyRα4 and found glycinergic sIPSC frequency indeed decreased after the loss of 
the GlyRα4, yet some glycinergic sIPSC activity remained, presumably mediated 
by GlyRα2. This result suggests that any method of glycinergic sIPSC activity 
compensation occurs during or before synapse development, or is dependent on 
the loss of GlyRα4 on presynaptic amacrine cells. 
II. FURTHER DIRECTIONS 
  
GlyR function is dependent on the release properties of the presynaptic 
amacrine cells. Using known labeled presynaptic amacrine cell and post-synaptic 
ganglion cell pairs could aptly reveal glycine receptor function. An example would 
be to explore the glycine release properties of the Vglut3 amacrine cell onto the 
W3B cells (specifically LED cells as opposed to the other cells labeled in the W3B 
line (HD1, HD2, or UHD cells) (T. Kim et al., 2015). The W3 cells express both 
GlyRα1 and GlyRα3 in different synapses. The Vglut3 amacrine cell may release 
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glycine onto only one receptor subtype. It is also possible that the co-expression 
of glycine receptors enables coordinated inhibitory kinetics, which would be 
impossible from single GlyR expression. I.e., the cooperation between co-
expressed GlyRα1 and GlyRα3 on LED cells would be different from the individual 
expression of GlyRα1 or GlyRα3. If these co-expressing GlyRs have a harmonious 
function, then the tuning of the inhibitory signal is more acute than what can be 
created by the four individual receptors subtypes alone.  
This idea of harmonious function among two co-expressed GlyRs has not 
been observed. Instead, the need for the variety of different GlyR decay kinetics is 
observed in two different types of cells of the VCN. The bushy cells and the T 
stellate cells of the VCN express different subunit specific GlyRs, which individually 
mediate the temporal inhibition differently (slow kinetic GlyRs increase the spike 
threshold improving spike precision in bushy cells while fast kinetic GlyRs mediate 
rapid inhibition that preserves the spike threshold and eliminates poorly timed 
spikes improving spike timing in T stellate cells (Xie & Manis, 2013). Given the 
variety of visual response properties of the forty different retinal ganglion cell types, 
it should not be surprising that there is a need for four different subunit specific 
GlyRs. The different GlyRs likely play unique roles in modulating the different 
excitatory input into each different RGC type. For instance, the kinetically slow 
GlyRα2 and GlyRα4 likely improve spike precision in the ooDS, ON SAC and J-
RGC cells in a similar manner to the bushy cells of the VCN. Then, kinetically faster 
GlyRs expressed on the W3 cells may match their inhibitory input with fast 
excitatory input, like the T stellate cells of the VCN, to not interfere with the 
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membrane potential, but instead improve excitatory spike timing output and inhibit 
poorly timed spikes.
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